Estimation and hypothesis testing with additive kernel machines for high-dimensional data by Clark, Jennifer
ESTIMATION AND HYPOTHESIS TESTING WITH ADDITIVE
KERNEL MACHINES FOR HIGH-DIMENSIONAL DATA
Jennifer J. Clark
A dissertation submitted to the faculty of the University of North Carolina at Chapel
Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in














JENNIFER J. CLARK: Estimation and Hypothesis testing with Additive
Kernel Machines for High-Dimensional Data
(Under the direction of Dr. Mike Wu)
Advances in high throughput biotechnology have culminated in the development of
large scale, population based studies for identifying genomic features (e.g. genes, SNPs,
CpGs, etc.) associated with complex diseases and traits. Understanding an individual’s
genetic disposition for particular traits and diseases can provide information toward the
development of individualized risk profiles and treatment regimes and simultaneously
provides clues as to the biological mechanisms underlying complex traits. However, the
high-dimensionality of the feature space, the limited availability of samples, and our
incomplete understanding of how features biologically influence various diseases impose
a grand challenge for statisticians. To mitigate some of these challenges, we propose
several new methods. First, we develop the additive least square kernel machine (AL-
SKM) approach for nonparametrically modeling and testing the cumulative effect of a
group of features (such as multiple biologically related CpGs) while nonparametrically
adjusting for complex, nonlinear covariates. Our proposed methods model both the
genomic features and the complex covariates using the kernel machine framework. Sec-
ond, building on the ALSKM, we develop a novel approach for testing for interactions
between two different groups of (biologically related) features. Specifically, we develop
a multi-marker test which can test for epistasis, or gene-gene interactions, between two
different groups of genomic features. Finally, we again use on the machinery developed
under Topics 1 and 2 to develop an approach for testing the association between rare
variants and a phenotype in the presence of common variants while accommodating
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potential interactions between the common and rare variants. By focusing on multi-
feature testing, these approaches reduce the dimensionality of the data. Using the
kernel machine framework allows for flexible, possibly nonparametric, analysis which is
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Advances in high throughput biotechnology has led to development of array and se-
quencing based methods which can genotype hundreds of thousands of single nucleotide
polymorphisms (SNPs) in a large number of individuals. This has in turn culminated
in the development of population based genome-wide association studies (GWAS) for
identifying SNPs associated with complex diseases and traits. Understanding an indi-
vidual’s genetic disposition for particular traits and diseases can provide information
towards the development of individualized risk profiles and treatment regimes and si-
multaneously provides clues as to the biological mechanisms underlying complex traits.
However, although GWAS are responsible for identification of over 1000 SNPs asso-
ciated with a range of outcome variables, the total variability explained by the main
effects of the discovered SNPs accounts for only a fraction of the total variability that
is attributable to genetics. Searching for this “missing heritability” is an emerging goal
of modern genetics.
Recently, there has been considerable interest in examining the potential for epis-
tasis, gene-gene interaction, to explain some of the heritability and it has been hypoth-
esized that interactions between and among multiple SNPs can explain a considerable
portion of the missing heritability. However, the high-dimensionality of modern genetic
data, the limited availability of samples, and poor understanding of how epistatic ef-
fects influence the outcome pose a grand challenge for statisticians. The field keenly
needs powerful new statistical methods for interaction analysis that can accommodate
complex, high dimensional genetic data.
Multi-marker testing, wherein groups of related SNPs are taken and their cumula-
tive effect tested, has proven to be a useful strategy for analysis of genetic data. By
focusing on pre-defined groups of SNPs, one is applying biological regularization to
the high dimensional data resulting in a reduced penalty for multiple comparisons and
improved power to detect multi-SNP effects. Simultaneous consideration of multiple
SNPs grouped on the basis of a biologically relevant unit also allows for improved cap-
ture of untyped variants which are correlated with genotyped variants and improves
interpretability of results by directly making inference on a biologically meaningful unit.
Some methods now also allow epistatic effects. Although multi-marker testing has been
found to be a powerful strategy for analysis of main genetic effects or the joint main
effect and interaction effect, little methodological work has been done on multi-marker
interaction analysis.
In this dissertation, we develop a new strategy for multi-marker analysis of epistatic
effects based on the nonparametric kernel machine framework. Specifically, we have the
following three topics.
First, we develop some of the fundamental statistical machinery that is an inter-
mediate step in developing multi-SNP interaction methods. In particular, we proposed
the additive least squares kernel machine (ALSKM) approach for modeling and testing
the main effect of a group of genomic features (e.g. SNPs, genes, proteins, CpGs, etc.)
with a quantitative (continuous) outcome while adjusting for complex, possibly nonlin-
ear and interactive, covariates. Existing methods can allow for complex genomic effects
but generally require adjusting for covariates (other genomic features or environmental
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factors) in a simplistic, linear fashion. In practice, however, the relationship between
the covariates and the outcome can be complex. Consequently, we propose methods
to model both the genomic features and the complex covariates using the kernel ma-
chine framework previously developed for support vector machines. Specifically, we
model the outcome as an additive function of the covariate effects and the effects of the
genomic features. In addition, we establish and exploit close connections with linear
mixed models to allow for estimation and testing within the kernel machine setting by
using the statistical machinery developed for regression and mixed models. We demon-
strate via simulations and real data applications that our approach allows for accurate
modeling of covariates and subsequently improved power to detect true multi-feature
effects and better control of type I error when covariate effects are complex, while los-
ing little power when covariates are relatively simple. The method was applied to an
epigenetic study of birth weight.
Second, we build upon the machinery developed in our first topic to develop an
approach for analysis of epistasis using multi-marker tests. Specifically, we develop
a gene-level test called the SNP-set kernel interaction test (SKIT) which can test for
epistasis between two different groups of SNPs, grouped on the basis of prior biological
knowledge, e.g. in a gene. We note that the relationship between two groups of markers
can be modeled as the sum of the main effects of each group (with possible interactions
within each group) and the interactive effects. Consequently, this can be considered
an ALSKM model. The difficulty is in determining an appropriate kernel for modeling
the interaction terms which allows for interaction between the SNPs from different
genes without including the main effects. We consider a kernel principal component
analysis approach for isolating the components of interest and employing the estimation
and testing framework from the previous topic to conduct testing. Simulations for the
SKIT show a protected type I error and power in finding significant epistatic effects in
3
a candidate gene study of birth weight.
Finally, we again build on the machinery developed under Topics 1 and 2 to develop
an approach for testing the main SNP effects along with potential epistatic interactions
that are outside the feature set of interest. There has been recent work and considerable
interest in testing main effects with complex interactions, yet existing work does not
generalize easily to the multi-marker setting and is technically challenging. However,
following from similar ideas in Topic 1 and 2 we can isolate the effects for a feature
set of interest along with interactions with features outside the set in order to test for
significance while adjusting for main effects that are in epistasis with the main feature
set. There has been a disappointing lack of results from methods based upon the
common disease, common variant hypothesis. There are a number of challenges in the
realm of rare variant testing, one being an inflated type I error when common variants
are not adjusted for in the procedure. This has investigators looking to combine ideas
behind the common variant and rare variant hypotheses. The method presented in this
last chapter relates ideas from both hypotheses as we can test for the significance of
a set of rare variants along with any modifications they may have on variants with an
association on the given trait or disease while simultaneously adjusting for the main




2.1 Genome-wide association studies
One of the major objectives in modern genetics is the identification of genetic vari-
ants that are associated with an individual’s risk for developing complex diseases or
other complex phenotypes and traits. Understanding which genetic variants drive par-
ticular complex traits or disease can allow for development of individualized risk profiles
and for improved understanding of the biological mechanisms underlying disease devel-
opment. Traditionally, strongly hypothesis driven candidate gene approaches were used
to identify associations between individual single nucleotide polymorphisms (SNPs)
(149). Using prior biological knowledge and hypotheses concerning the mechanisms
underling the complex traits, such studies involved genotyping a few selected tag SNPs
(145) within the candidate gene(s) on a generally modest number of individuals, and
then testing for associations with the complex trait of interest. While candidate gene
studies were successful in identifying SNPs associated with a wide range of complex
traits (32, 35, 6, 48), they captured only a small proportion of genetic variability and
relied strongly on prior biological knowledge which is subject to investigator bias. It
was recognized that agnostic approaches that provided comprehensive coverage of the
entire genome were necessary yet technological developments lagged behind scientific
interest.
Starting with the development of microarrays for gene expression data (15), array
based approaches became standard strategies for understanding biological systems and
spurred considerable research into high throughput biotechnology. Within the con-
text of genotyping, this culminated in the development of array based platforms for
simultaneously genotyping hundreds of thousands of SNPs across the genome at a rel-
atively low cost. These developments in turn spurred the development of large scale
genome-wide association studies (GWAS) (58) which involves genome-wide genotyping
of a large number of individuals through large cohort studies or case-control studies.
Standard analysis of GWAS proceeds via individual SNP analysis. In particular,
after quality control, each SNP is tested one-by-one for association with the complex
trait or disease phenotypes. SNPs that reach significance after correcting for multi-
ple testing are then reported. Alternatively, due to the large multiple testing burden
and costs, a two-stage approach was applied: in a discovery phase, GWAS were used
to prioritize individual SNPs for association with the outcome, then in a subsequent
validation phase, the top SNPs from the discovery phase were replicated in a separate
cohort. The focus, however, remained on examining the effect of each individual SNP.
Using this approach, GWAS have been responsible for identifying over 1000 SNPs (56)
associated with a wide range of traits and diseases as breast cancer (59, 39), prostate
cancer (167, 50, 151), and type 2 diabetes (144, 139, 130).
2.1.1 Missing Heritability
Current strategies in GWAS to reveal the genetic architecture underlying the hu-
man condition have thus far failed to unearth variants that collectively explain a large
proportion of genetic risk (40). Considering the extensive amount of time and resources
6
allotted to GWAS, the actual effects and contributions to elucidating the genetic archi-
tecture of common complex diseases and genetic risks has been somewhat underwhelm-
ing. Throughout all the studies in the literature there are few replicable SNPs with odds
ratios going above 1.3 for common human diseases. This limitation has investigators
questioning whether SNPs which are identified through GWAS make poor classifiers of
disease (108, 158) especially since even the combined effect of the discovered individual
SNPs is still small. The relatively small number of positive results can be due to a
range of methodological difficulties related to standard analysis approaches as well as
challenges concerning alternative hypotheses for the genetic basis of complex trait.
Some of the missing heritability is inevitably explained by undiscovered genetic
loci which are difficult to detect using the simplistic single SNP approach currently
used in GWAS analysis. Despite the success of single SNP analysis, a number of
studies have shown that such analyses can be dramatically underpowered and have
apparently poor reproducibility. One reason for the lack of power is simply due to the
ultra-high dimensionality of the data. For example, a standard GWAS with 500,000
SNPs would have an adjusted α level as stringent as α = 10−7. Modern GWAS are
typically analyzed with α = 10−8. Separately, most SNPs genotyped in GWAS will
only show modest effects. One explanation for this phenomenon is that the causal SNP
is rarely the genotyped SNP. Instead, GWAS may capture SNPs that are in linkage
disequilibrium (LD) with the causal SNP making them imperfect surrogates for the
causal SNP. Testing the joint effects of multiple SNPs together, even if they are only in
LD with the causal SNP, could more effectively capture the effects than an individual
analysis of each SNP. Similarly, the apparently modest main effects can be due to true
multi-SNP effects. Individual-SNP analysis can only examine the marginal effects of
each SNP and will generally fail to detect the effects of multiple SNPs with individually
modest effects.
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In addition to methodological issues, it is entirely possible that the heritability is
simply not captured by the effects of the SNPs being measured. For example, recently,
there has been considerable interest in understanding the influence of rare variants,
SNPs with allele frequency less than 1-3% in the population which are now detectable
due to advances in DNA sequencing (104, 2). The hypothesis is that rare variants may
have larger effects on complex traits since they have not been exposed to the same
degree of evolutionary pressure and natural selection as common variants (12, 76).
However, despite some successes (such as Cohen et al. (2006) (27), Emond et al.
(2012) (42), and others) and considerable methodological interest (4, 52, 76, 77, 79,
97, 110, 111, 123, 165), the results from searches of rare variants have, thus far, been
generally disappointing (65).
In addition to the role of rare and undiscovered variants, a separate challenge lies
in the identification of epistatic effects which are also anticipated to explain much of
the missing heritability (102, 40). Recent studies suggest that as much as 80% of the
heritability for some traits could be due to gene-gene interactions (173), yet detection
of such epistatic effects are generally challenging and underexplored.
2.2 Statistical Analysis of Epistasis
In order to further our understanding of issues such as individualized medicine,
pharmacogenetics, underlying biological mechanisms for various traits and diseases,
and discovering current unexplained heritability, it is imperative that we identify ge-
netic variants with interactive effects. Due to the limited effects that can be detected
in the single SNP association studies, more attention has been given to constructing
multi-SNP interactions in order to find more significant associations. Such multi-SNP
interactions are known as ‘epistatic interactions’ (158). Historically, epistatsis was de-
fined as the change of segregation ratio and the interaction of genes. Bateson was
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the first to coin the term ‘epistatic’ in his 1909 paper on Mendelian heritability. His
definition is analogous to the concepts typically applied by biologists and biochemists
when exploring biological interactions between proteins (9). However, the exact def-
inition of epistatsis is still currently being debated within the literature. The literal
meaning behind the term “epistasis” is “standing upon”. From a biological perspec-
tive epistasis occurs at a cellular level. Bateson viewed epistasis as an extension of
Mendelian concepts of dominance for alleles at a single locus, in order for underlying
hypostatic characters to be seen the epistatic characters must be removed. From a sta-
tistical viewpoint we see epistasis as a pattern of genotype-to-phenotype relationships
resulting from genetic variation within the population. It is important to be able to
distinguish between these two views when seeking to make biological conclusions from
a statistical model (108).
Penetrance, the probability of developing a disease given a certain genotype, is
typically what is assessed within mathematical models examining the combined actions
of multiple loci. Penetrance tables have classically been used to illustrate epistasis or
the lack thereof. Some of the uncertainty on determining whether epistasis is present
stems from differences on how investigators decide to test for it. Some assume that
epistasis is a departure from additivity on the penetrance scale; others believe that it is
a departure from multiplicativity on the same scale while still others view epistasis in
terms of epistatic variance or the amount of variation of a trait that can be explained
by epistatic effects.
In his 1918 paper, Fisher applied the term ‘epistasis’ in a more statistical sense than
its initial usage. He drew on the idea of a statistical interaction which describes the
relationship between the predictive factors of alleles at different loci as a departure from
a specified linear model. When applying this definition we must be conscious of the
scale that is being used. Additive factors with respect to the outcome may no longer be
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additive and show signs of interaction when transformed. Transformations such as log
or logit can change addative models to that of heterogeneity and multiplicative models
with epistatic interactive effects. The multiplicative model of the form pij = αiβj
where αi are the effects of genotype i at locus 1, βj are the effects of genotype j at
locus 2, and pij is the penetrance for genotype i at locus 1 and j at locus 2 can be
considered an epistatic model where the loci and pathways relevant to the disease are
not independent. Non-epistatic models which are generally considered to correspond
to the condition where biological pathways are deemed to be separate or independent
are represented with additive and heterogeneity models. The classical heterogeneity
model where a genotype at either locus 1 or 2 predisposes an individual can be written
as pij = αi + βj − αiβj where α0 = α1 = β0 = β1 = 0 and α2 = β2 = 1. When
penetrances pij are no longer 0 or 1 the biological interpretation of this heterogeneity
model becomes ambiguous (29).
When epistasis is detected it is suggestive that there is a biologically interesting
phenomenon and the mechanisms and pathways involved are relevant to the disease,
especially biological interactions between the affected proteins. Often confusion from
biologically motivated definitions of epistasis stems from a vague sense on what is meant
by an ‘effect’ or ‘independence of effects’. Current statistical tests for interaction are
testing specified hypotheses on defined quantities which renders testing for abstract
biological concepts of ‘independence’ or ‘masking’ impossible under existing methods
since an interaction at the biological or mechanistic level is not necessarily implied by
a significant statistical interaction. These procedures are also only designed to test for
epistasis between those loci that are genotyped; if these variants are not the actual
etiological variants but are merely in linkage disequilibrium with the true variants then
the epistatic effects between the surrogate loci that was genotyped will be weaker than
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when measured against the true variants. These concerns illustrate many of the diffi-
culties that current methods face in formulating an accurate biological interpretation
from the quantitative data. Finding new and more powerful methods is important for
discovering possible interactions between disease loci which can lead to an improvement
in power to detect genetic effects (29).
2.2.1 Challenges/Goals for Epistasis
While the age of cheap genetic testing is quickly approaching, fostering the idea of
personal genetics, limitations such as being replicable and small odds ratios pose the
critical question of how useful genetic testing is for risk assessment. It is thought that
epistasis plays a key role in the genetic architecture of common diseases; the lack of
consideration that it has been given is one of the main reasons for the disappointing
results that GWAS has thus far yielded (108).
Statistical methods within the epistatic literature attempt to detect k-SNP epistatic
interactions, for k ≥ 2, that are significantly associated with the phenotype of interest.
For many of the methods k is simply set to be 2 and a list of epistatic interactions
along with the significance after correcting for multiple testing is output. When just a
two-loci epistasic interaction is present then the effects of one locus can be altered or
masked by the other locus. This will reduce the power to detect the first locus which
will, in turn, hinder the elucidation of the joint effects (29). Another challenge facing
these methods is how fast the number of interaction tests grows as k increases. There
is a n-fold increase (n being the number of SNPs in the dataset) in the number of
tests alone when k goes from testing only main effects to two-way interactions. As k
increases the total number of tests increases which eventually leads to a failure in all
the current methods, so none of the current methodologies can test all the combinations
of epistatic interactions for any reasonable dataset. These heavy computational costs
11
pose a lofty challenge for the methods (158). There is also the problem of correcting for
type I error while retaining adequate power. In testing a substantial number of epistatic
combinations it is expected that many of these would in fact be false positives wherein
the problem becomes how to correct for this. Further success beyond the current
methods will be able to identify genetic variants that would have remained undetected
by allowing for epistatic interactions between prospective disease loci. New methods
that are able to identify the most parsiminous model for joint effects of different loci
and their interactions can be applied to towards prediction of phenotypes and targeted
interventions (29).
2.2.2 Methods used in Testing for Epistasis
There are many new methods that have been proposed for detecting epistatic inter-
actions in GWAS data. Typically, model-based methods will have a predefined model
relating phenotypes and genotypes. Once the data has been fit to the model, testing is
done and significant SNPs are output. Previous methods have only worked well when
modeling only a few important candidate SNPs that have been filtered. As the number
of SNPs grows, these methods often begin to fail. Many different heuristic and filtering
techniques have been implemented within this methodology in order to make it more
efficient.
BOOST is a method which has a new Boolean representation of the data for the
epistatic detection problem. With this new representation investigators are able to
use the established methods of logic operations to efficiently collect contingency table
information. The authors also offer an upper bound of the likelihood ratio test statistic
for two-locus epistatic interactions in order to trim the search space of insignificant
interactions (156).
Screen and Clean is a two-stage analysis method. The analysis was designed so
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that the overall procedure would be more efficient. In the first stage only tag SNPs
and marginally significant SNPs are considered. A main effect lasso logistic regression
model is fit for the encoded phenotype values (0 or 1) and genotype values (0, 1, or
2). The SNPs with coefficients that satisfy the criteria of βj 6= 0 for j ∈ {1, 2, . . . , n}
are identified by the model and the least square estimates for these SNPs along with
a t-test for significance are calculated. SNPs found to be significant are entered into
an interaction model. After this the SNP pairs are put into a second cleaning stage
to control the type-1 error. A t-test is implemented to remove those SNP pairs whose
significance does not reach the user defined threshold (160).
SNPHarvester is a stochastic search algorithm developed in order to identify 40-
50 groups of candidate epistatic interactions. This method is a two step process first
filtering the data and then model-fitting. Since SNPHarvester is only interested in
epistatic interactions with weak marginal effects but significant joint effects it first runs
a χ2 test on the single SNPs and filters out those that are found to be significant. From
this it forms and active set of randomly chosen k-SNPs, S = {SNP1, SNP2, . . . , SNPK}
with all the rest of the SNPs forming a candidate set SC . By swapping out SNPi ∈ S
with SNPj ∈ SC a total of k(n − k) combinations are tested and the group with the
highest χ2 value is removed and a new active set of k-SNPs is found and the remaining
n − 2k SNPs form the candidate set. This procedure is repeated until m groups are
identified. Once these groups have been found they are fit into the L2 penalized logistic
regression model (166).
Other methods developed to test epistatic interactions have no prior assumption
on the data. These methods assess the test statistic of each epistatic interaction with
phenotypes given the genotype. An exhaustive algorithm called TEAM is run in order
to test for two-locus epistatic interactions. A permutation test, which is generally
considered to be more accurate than direct adjustments such as Bonferroni but at a
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higher cost, is used to control the type-1 error. P-values are calculated based on all
the permutations of the contingency tables for every pair of SNPs. In order to cut
down on costs, this method groups those with the same genotype values together when
computing contingency tables and only considers those individuals which have different
genotype values. A minimum spanning tree (MST) structure is used to represent the
data and an exhaustive search of all the epistatic interactions is done by traversing the
MST. Since TEAM does not assume any sort of model, any test statistic that can be
found from the contingency table, such as χ2, exact likelihood ratio test and entropy-
based testing, can be applied. By using the MST this method is an order of magnitude
faster than a brute-force approach (171).
A pattern-based method called SNPRuler connects epistatic interactions with pre-
dictive rules in order to implement a data mining approach. The quality of the rules
that are induced by the epistatic interactions is given by the χ2 test values. A set
enumeration tree is created and then pruned using an upper bound proposed by the
authors on the χ2 statistics. The rank SNP-level interactions are found in a post-
processing procedure after the search process has been completed (156). One of the
key drawbacks to this methodology is the the upper bound for the χ2 statistic is not a
true upper bound as it does not possess the anti-monotone property (1), so it could be
pruning out many of the true-positive epistatic interactions. There is also the incon-
venient assumption placed on the upper bound that the number of cases is at least as
large as that of the controls which is usually not the case in most studies.
These recent methods were compared in a review paper by Wang et al. Power and
type-1 error were tested under several different settings. The first setting uses data that
has both main and interactive effects. Within this setting two MAFs of 0.2 and 0.5
were used with λ set at 0.2, 0.3, and 0.5 to control the main effect of the ground-truth.
In all the simulations under this setting TEAM consistently outperformed all of the
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other methods. However, this method is also the slowest of all the methods due to
the fact that it is only an order faster than using a brute-force approach and it uses
permutations which makes it a more expensive procedure to implement.
The other setting used data that had a strong interactive effect but lacked main
effects. Many of the methods are not equipped to handle such data so finding such
epistatic interactions remains a challenging ‘dark area’ within the literature. Two
different MAF settings of 0.2 and 0.4 were used with seven heritiability settings of
0.4, 0.3, 0.2, .1, 0.05, 0.025, and 0.01, and five different penetrance tables. Under
these settings BOOST consistently had the highest median power. When heritability is
relatively low all of the methods had low power. Under this setting, when heritability
was set to 0.001 with a MAF of 0.2 and only 200 samples all of the methods had no
power to detect epistatic interactions. However, increasing the sample size seemed to
predictably improve the power in all four methods tested.
While BOOST seemed to perform best in the presence of interactive effects, it
may not perform very well when the interaction terms are not significant contributors.
Procedures that may not be able to detect the ground-truth without the presence of
interactions are testing what is referred to as ‘statistical epistasis’ (29).
No one method was found to be best for all settings. Depending on the type of
data, time, and computational resources that are available any one of the methods
listed here could be applied (158). Methods within the realm of statistical epistasis are
quite complex and can lead to results that are left wanting in their ability to capture
higher order, low impact features. This has left room for new and improved statistical
methods in order to capture these higher order, more complex epistatic interactions.
A fundamental limitation of these methods is that the emphasis is still on simplis-
tic two-way interactions and on univariate analysis for the main SNP effects. Deep
interactions or scenarios where main effects have extremely modest effects yet strong
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interactions will be missed. Further, even using permutation for analysis, the number
of interactions is still large. New statistical methods based on multi-SNP analysis can
not only reduce the multiple testing burden but can potentially also allow for complex,
deep interactions and nonlinear SNP effects.
2.3 Multi-feature Testing
Multi-feature testing is a new category of testing methodology where groups of re-
lated features are grouped together in order to test their cumulative effect. Often these
groupings are made based on prior knowledge and have been shown to have marked
improvements over individual feature analysis. Several different types multi-feature
testing have been developed within the statistical literature. Originally developed for
gene expression analysis (67, 109), such methods have become powerful approaches for
analysis of GWAS as well.
2.3.1 Marker-set Analysis
Marker-set analysis is defined as the joint evaluation of a group of markers for genetic
association. Although one can simultaneously analyze a range of genomic features
such as SNPs, insertion-deletion variants (INDEL), block substitutions, copy-number
variants, inversion variants, etc. together as a unit, within the context of genetic
association analysis focus has primarity been on groupings of SNPs. Typically these
SNPs share some common chracteristics such as their proximity to genomic attributes
such as genes, haplotype blocks, pathways, evolutionarily conserved regions, or being in
high linkage disequilibrium. In the past, most marker-set methods focused on detecting
genetic main effects. However, by defining units by genes, pathways, or functions,
marker-set analysis provides a biologically sensible element for the genetic component
and conveniently can allow for loci in a set to be assessed jointly for their effects under
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various environmental exposures. By using a collapsing method such as marker-set
analysis there is a gain in power not only from the alleviation of the data-hungry
nature in testing multiple interactions, but also in the reduction of the multiple-testing
penalty (155).
In marker-set analysis the features are first put into sets which are devised based
on meaningful biological criteria. Testing is then performed on the sets to detect
associations with the disease outcome. By grouping features together based on prior
biological knowledge this strategy allows the testing procedure to borrow information
from different correlated features within the set. This is similar to what happens
when performing any multi-feature analysis, because testing whole units rather than
individual features reduces the number of testing procedures being run which helps
ease stringent corrections made on α for type I error. In addition to relaxing these
conditions, when sets are put together properly, marker-set analysis will have improved
power to detect the effects of untyped causal features. Also, under certain multi-feature
methods like kernel machine testing procedures, nonlinear effects along with complex
epistatic interactions are also better handled as the joint effects of multiple causal
features within a set can be detected.
In doing a marker-set analysis, groupings can be made in any arbitrary manner and
the analysis itself will still be statistically valid as type I error should be preserved.
However, appropriately constructed sets based on prior biological knowledge can lead
to further gains in power as correlated markers within a set which are also correlated
with the causal feature will jointly have a stronger signal than testing each individual
marker. It is therefore advantageous to use prior knowledge to form the marker set as
the grouping can influence power. It may also be easier to interpret a set which was
formed based on prior biological knowledge (161).
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2.3.2 Methods for forming Sets
When sets are well-formed it can lead to greater power and interpretability of the
hypothesis test results. There are various grouping strategies that can be employed
when forming these sets. One such approach is to take the features on or near a gene as a
single set. Many genetic studies use SNPs as the markers or features as they are usually
what is most readily available when running a GWAS. In order to capture regulatory
regions in a set, SNP sets can be formed by taking SNPs between the beginning and
end of transcription while also including those that are both upstream and downstream
of the gene. Many of the typed SNPs within a gene will be correlated which will
improve the power for a kernel-machine testing procedure in detecting significant SNP-
set effects. Testing performed on gene-based SNP sets allows us to interpret and make
direct inference for significant associations between genes and disease outcome. The
number of hypothesis tests is also cut down when grouping based upon genes. The
Illumina HumanHap 500 array has approximately 530,000 typed SNPs, gene-based
SNP sets will par down the number of tests to around 17,800 (161).
Another approach for gene-based SNP-set analysis involves grouping SNPs based
upon gene pathways as defined in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) (115) or a Gene Ontology Consortium functional category (3). Pathway based
SNP set analysis will also reduce the number of multiple comparisons within the GWAS
while still allowing for an interpretation that is biologically meaningful.
Another grouping strategy is grouping SNPs based upon evolutionarily conserved
regions. This would help to augment the coverage of the genome as many variants that
may be associated with disease may lie outside the boundaries of known genes and
pathways. Evolutionarily conserved regions are thought to be of increased importance
or functionality (106). Even if the features within the set are not well understood,
significance of such a set could be indicative of a genomic feature that is related to
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disease. Full coverage of the genome can be realized through approaches such as the
moving window or haplotype blocks. In order to do this the genome would be divided
into a fixed number of adjacent regions based on length with each region treated as
a SNP set. However, there may not be as easy of an interpretation when using this
strategy as there is when using genes or pathways. Another alternative would be to use
haplotype blocks to form SNP sets. This could be done using such tools as Hoploview
(5).
A limitation of the gene and pathway-based SNP sets is the exclusion of intergenic
regions in the sets. If the causal SNP is not close to a known gene or pathway, then the
gene or pathway-based SNP sets will not realize the effect of interest. By adding ad-
ditional grouping strategies such as evolutionarily conserved regions, haplotype blocks,
or a moving window we can augment the coverage to include the entire genome.
Detecting interactions can be difficult when using a moving window or gene based
SNP set when the epistatic effects within the SNPs are not close to each other on the
genome. This is why it is important to use prior biological knowledge which could lead
to groupings that can more readily capture these interactions in areas where they are
likely to exist. It is likely that such interactions will lie within genes in the same pathway
or genes which have a similar function. As scientific knowledge and understanding of
the genome progresses, marker-set groupings will improve which will improve the power
in these testing procedures (161).
2.3.3 Previous Marker-set procedures
In previous testing procedures directionality of the effects of the alleles and whether
they are protective or deleterious was problematic. Alleles within the same set could
cancel out any effects they may have on the phenotype if they had opposite direc-
tionality. Directionality does not affect the power in the many kernel-machine testing
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procedures as it is robust to situations where combinations of multiple alleles could be
protective for some and deleterious for others in the same set.
One class of testing within SNP-set analysis involves multimarker methods based on
individual-SNP analysis. One of the more common approaches for assessing a SNP-set
is applying an individual-SNP analysis which involves testing each of the SNPs within
a set while correcting for multiple testing by means of Monte Carlo methods (80),
estimating the effective number of tests (25, 114, 112), or by combining the tests. Since
these procedures are based on individual-SNP analysis, they do not borrow information
across SNPs that could be correlated. This is quite problematic when the SNPs are not
in high LD with the causal variant. Individual SNP testing also cannot be adjusted to
account for complex genetic effects or epistasis.
Methods such as the LD-based weighting method, the weighted Fourier transform,
and PCA-based methods use a weighted sum of genotypes across markers in the unit.
In order to pursue a more focused analysis of rare variants, special versions of weighted-
sum methods based on allele frequencies have been proposed (13, 19, 21). U-statistic
approaches model the genetic similarity of pairs of individuals. SNP random-effects
models, haplotype random-effects models, and kernel-based methods are considered to
be Variance-component (VC) methods. These procedures use random effects to model
individual genetic effects in order to assess the global effect of a gene by testing the
corresponding VC. Other methods such as c-alpha tests, the group additive regression
model, Tukey’s model, and entropy-based methods do not typically correspond with
any well-known category and are therefore relegated to an amalgamated category of
such methods (155).
Another class of testing procedures is known as omnibus testing which implements
a simultaneous analysis for all features. This is typically done for multiple SNPs or
haplotypes using multivariate regression (133, 169). These testing procedures require a
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considerable number of degrees of freedom which often undercuts their power making
them little better than individual-SNP analysis (23, 126). While there have been new
methods proposed to reduce the number of degrees of freedom, they still run into
other common problems within the GWAS testing framework like directionality (132),
computationally expensive permutations making them impractical for GWAS, or not
allowing for covariate adjustments (161).
When running simulations comparing the logistic kernel-machine test with popular
omnibus testing procedures Wu et al. found the size for all the tests were correct
only when demographic and environmental covariates were simulated independently of
the genotype information. Even just adding modest correlation (ρ = 0.065) led to an
inflated type I error for the omnibus testing procedures which fail to adjust for these
covariates (161).
A different class of SNP set testing uses explicit population-genetics models to
identify the causal locus. Most methods within this class work by reconstructing the
sample phylogeny, this reconstruction will guide the analysis in order to extrapolate the
causal mutation (107, 150). There is an automatic assumption here that the population-
genetics model is true which can lead to higher power when this is the case. It is
difficult to validate this assumption in real data and often the procedures for this
model are computationally intense and must be simplified for application. There is
also the problem of covariate adjustment which most models within this class do not
allow for (161).
2.4 Kernel Machines for Estimation and Testing Multi-Marker Effects
Kernel machine methods have become popular recently due to the development of
support vector machines (SVMs) (30) which arose due to the need to learn classifiers
from high-dimensional data. There is a rich class of regularized, non-linear prediction
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methods that are possible through utilization of the kernel machine framework which
have been applied to a range of prediction problems (64, 117, 37, 51). The sheer
abundance and popularity of applications as well as computational algorithms related
to solving SVMs (22, 116, 137, 122) is a testament to how powerful these methods
are. In a prediction setting, function h is selected to map the data points z to y ⊂ R.
A prediction rule, h, can be selected using a kernel machine. This is done through
balancing the complexity with the empirical loss of the decision rule on a training
dataset. The kernel machine is defined over the training data set, S, for a specified
Mercer kernel using optimization over the Reproducing Kernel Hilbert Space (RKHS)










The loss function is typically chosen to reflect the prediction class at hand such as
classification, regression, ordinal regression, etc. The space for the candidate predictors,
h, is determined by the kernel. The parameter λ controls the tradeoff between the goal
of minimizing empirical error while simultaneously minimizing predictor complexity
(96).
One of the appealing attributes of SVMs and, indeed, the whole class of kernel
machine methods is the capacity to attain a non-linear, potentially infinite dimensional
predictor within a feature space. This is done efficiently without explicitly mapping
points into the feature space through use of the Representer Theorem and the kernel
trick(69). This theorem indicates that if h(z) is a solution for the optimization problem




i , z) (31).
Many techniques based off of kernel machines are able to detect complex/nonlinear
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relationships between independent and dependent variables (31, 14). The kernel func-
tion, K(., .), projects the genotype data from the original, possibly infinite space into
another space. From this new space h(.) can be modeled in a linear fashion whereas
before, in the original space, h could be highly nonlinear. It may be more intuitive to
think of K(zi, zi′) as a measure of similarity between the genotypes in the i
th and the
i′th subjects. The more complex the kernel function becomes then the more complex
the function space from which we are mapping these measures becomes.
Although the emphasis within the statistical learning field is on classification using
kernel machine methods, we will primarily focus on the regression setting. Regression
based kernel machine methods include support vector regression(36, 7), kernel logistic
regression (172), and the least squares kernel machine regression the equivalent kernel
ridge regression (128) among others. Of these, support vector regression has become
popular within the machine learning field due to their similarity with SVMs and attrac-
tive computational properties. However, recent work within the statistical literature
on the least-squares kernel machines has suggested close relationships with classical
linear mixed models and consequently attractive statistical properties which can be
exploited for estimation and hypothesis testing (89, 87, 121). These have been adapted
for multi-feature testing.
2.4.1 Least-Squares Kernel Machines
Least-squares kernel machines (LSKMs) have been surfacing in the genetics liter-
ature as having flexible processes for modeling and testing the joint effect of multiple
genes. Kernel machines are popular within the statistical literature for modeling high-
dimensional biomedical data. Kernel machine testing was first proposed by Liu et al.
(2007)(89) for continuous data and Liu et al. (2008) (87) for dichotomous data within
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the gene expression framework for both modeling and for hypothesis testing. The ap-
proach was then extended to analysis of genotype data by Kwee et al. (2008) (71) and
Wu et al. (2010) (164). Here, we briefly review the original kernel machine approach for
estimation and for hypothesis testing within the context of genetic association studies
and continuous traits.
2.4.2 Least Squares Kernel Machine Model and Notation
Under the kernel machine regression framework, continuous (quantitative) traits can
be related to the genotypes and any additional covariates through the semiparametric
model:
yi = β0 + β
′Xi + h(Zi) + εi (2.2)
where yi denotes the trait value for the i
th person in the sample, Xi is a set of covariates
for which we would like to control, and Zi = [Zi1, Zi2, . . . , Zip]
′ is the vector of genotype
values for the p SNPs in the SNP set. For simplicity, we assume that there is a single
SNP set of interest that is defined a priori. Under the commonly used additive genetic
model, each Zij is trinary variable equal to 0, 1, or 2 for non-carriers, heterozygotes, and
homozygous carriers of the rarer allele. εi is an error term with mean zero and variance
σ2, β0 is an intercept, and β is the vector of regression coefficients for the covariates.
h(·) is a generally specified function that lies within a functional space HK generated
by a positive definite kernel function K(·, ·). Then h(Z) = ∑Jj=1wjφj(Z) for some set
of basis functions φ(Z) = [φ1(Z), φ2(Z), . . . , φJ(Z)]
′ where J is possible infinite and the
wj are some coefficients corresponding the respective basis function. Under the kernel
machine framework, K(Zi,Zi′), which is the kernel function evaluated at the vector of
genotypes for subject i and subject i′, is equal to< φ(Zi)φ(Zi′) >=
∑J
j=1φj(Zi)φj(Zi′)
and the norm of the function h(·) on this space is ||h||H = w′w where w = [w1, . . . , wJ ]′.
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2.4.3 Kernels
Intuitively, K(Zi,Zi′) is a measure of the similarity between subjects i and i
′ based
on the genotypes of the SNPs in the SNP set, and importantly, the kernel function
fully specifies the relationship between the trait and the SNPs in the SNP set, and vice
versa. For example, it can be shown that if K(Zi,Zi′) = ZiZ
T
i′ , called the linear kernel,
then this implies that h(Zi) = α
′Zi for some vector of constants α, i.e. h(Zi) is a linear
function of the SNPs in the SNP set. The converse is also true: setting h(Zi) = α
′Zi
also implies that the kernel function is equal to the linear kernel. Hence, by selecting
and changing the kernel function, one is implicitly selecting and changing the model
being used.
There are several different classes of kernels that can be used from the statistical
learning literature. Classical kernels are what is typically used in practice as they
have been studied extensively and found to have notable discrimination in a variety
of settings and prediction tasks. Some popular kernels within this category include
the Gaussian kernel of radial basis, polynomial, and linear kernels. Domain-specific
kernels are kernels that may be well suited for only certain settings or applications.
Kernels within this category include the Pearson correlation kernel, K(x, y) = Kcorr =
corr(x, y), and the squared correlation kernel, Kcorr
2
= KcorrKcorr, which are used in
a collaborative filtering setting. The identity kernel, δ(x, y) = I(x = y) remains in
a classification by itself as it maximally distinguishes objects to induce separability.
Attribute kernels are kernels which affect the kernel machine model by allowing for the
amalgamation of external data, such as outside environmental factors, into the model
(96).
The choice of the kernel typically depends on the data and the type of function
space in which is lies. Two well known classical kernels within the machine learning
literature are the Gaussian kernel and the linear kernel. The linear kernel is considered
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the one of the simplest kernel functions as it can only pick out lines or hyperplanes in
a function space. However, if the data truly lie in this space then the linear kernel has
been known to outperform other more complex kernels. The Gaussian kernel is a more
complex function of radial basis which is better suited for nonparametric data. The form
of this kernel is K(Z1,Z2) = exp(− ||Z1−Z2||2ρ ) where ||Z1 − Z2||2 =
∑p
k=1(Z1k − Z2k)2.
The tuning parameter, ρ, can sometimes be estimated through optimization procedures,
but typically it is held fixed at a designated value in machine learning literature. For
values of ρ that are overestimated, the Gaussian kernel will begin to behave in a more
linear fashion and begin to lose its non-linear power. When ρ is underestimated the
kernel will lose regularization making it more sensitive to noise in the data (90).
While any single kernel could be used on its own within the various kernel method-
ologies, previous studies have shown that using combinations of kernels can lead to a
greater predictive power. Using the correct combination of kernels can also lead to
sizeable reductions in generalization error as reported by Basilico et al. when following
an composite kernel machine approach. Use of the identity kernel in composition with
other kernels has been shown to induce data separability thereby extending the appli-
cability of certain algorithms that could otherwise be difficult or impossible to estimate
(96).
Some examples of commonly used kernel functions for genotype data include:
• Linear Kernel: K(Zi,Zi′) = Z′iZi′





• Quadratic Kernel: K(Zi,Zi′) = (Z′iZi′ + 1)2
• IBS Kernel: K(Zi,Zi′) = (2p)−1
∑p
j=1 IBS(Zij, Zi′j) = (2p)
−1∑p
j=1(2 − |Zij −
Zi′j|)
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The Linear, Quadratic Kernels, and two-way interaction kernels are classical kernels
which work well for genotype data while the IBS is domain specific. Importantly, the
relative performance of these kernels has only been explored within the context of main
SNP effects and improved performance of other valid kernels, i.e. satisfy Mercer’s
theorem (31), may be possible within the context of interaction analysis.
Often, instead of specifying the kernel function K(·, ·), a corresponding kernel ma-
trix, K, is chosen. The kernel matrix is specified as a n × n matrix with the (i, i′)th
term equal to K(Zi,Zi′). However, a kernel function is not necessary as estimation
under the kernel machine framework depends on information in Z through the kernel
matrix, such that technically only a positive semidefinite K need be specified, which
can thereby circumvent the specification of the kernel function. This can allow for
tremendous flexibility since technically only a similarity matrix needs to be defined.
This could be done when investigators have little sense of the underlying model.
2.4.4 LSKM: Connection with Mixed Models and Estimation
Estimation within the least squares kernel machine framework can be done via




(yi − β0 − β′Xi − h(Zi))2 + λ||h||2H










subject to yi − β0 − β′Xi −wTφ(Zi) = ξi, i = 1, . . . n.
This can, in principle, be minimized to find ĥ(Z) = ŵφ(Z), but that requires specifi-
cation of the basis functions {φ1, · · · , φJ} which is high (possibly infinite) dimensional.
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However, under the representer theorem, there exists a dual representation to the pri-



















which has closed form solution: α̂ = (I + λK)−1(y − β̂0 − β̂′Xi) and ĥ = Kα̂ where
the β̂0 and β̂ are simultaneously estimated. The λ as well as other parameters within
the kernel (e.g ρ for the gaussian kernel) are usually selected via cross validation or
generalized cross validation.
Omitting details, Liu et al. (2007) (89) demonstrate that the score equations from
solving the dual objective function correspond exactly to the score equations from solv-
ing a linear mixed model. This suggests a strong relationship between kernel machine
models and linear mixed models. In particular, the connection with linear mixed mod-
els, allows Model (2.2) to be rewritten as:
y = β0 + Xβ + h + ε
where X = [X1,X2, . . . ,Xn]
′ is the matrix of covariate values, and ε = [ε1, . . . , εn]′.
Under this model h = [h(Z1), h(Z2), . . . , h(Zn)]
′ is a vector of subject specific random
effects with mean 0 and variance τK. One may then exploit the relationship with
mixed models in order to estimate h(Z) as a vector of random effects. This allows for
rapid estimation with the λ and the other parameters inside the kernel function to be
estimated as variance components without need for expensive cross validation.
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2.4.5 Least Squares Kernel Machine Score Test
In addition to advantages in terms of estimation, the connection between least
squares kernel machines and mixed models also allows for testing. This has been
exploited to develop a multi-marker test within the context of pathway analysis for
gene expression data and for SNP set analysis in genetic association studies.
Within the genetics context, the goal is to test whether the SNPs in the SNP set, Z,
are associated with the trait values, y. Since the trait depends on the Z only through
the function h(Z), to test the null hypothesis that no variants in the SNP set are
associated with the trait corresponds to testing whether h(Z) = h = 0. To do this, we
again exploit the close connection between LMM and kernel machine methods and note
that since h follows a distribution with mean 0 and variance τK, that testing H0 : h = 0
corresponds exactly to testing H0 : τ = 0 which can be done via a standard variance
component test. In particular, following the empirical Bayes framework of Zhang and
Lin (2003), the kernel machine test constructs the score statistic for quantitative traits
Q =
(y − ŷ0)′K(y − ŷ0)
2σ̂20
where ŷ0 = β̂0 + Xβ̂ with β̂0 and β̂ are estimated under the null hypothesis, i.e. under
the model where h = 0. Since all estimation is under the null, standard software for
least squares may be used to estimate all parameters.
In order to obtain a p-value for significance, it is straightforward to see that Q
asymptotically follows an unknown mixture of χ2 distributions. We can approximate




The original kernel machine method by Liu et al. (2007) (89) proposed to use the
Satterthwaite method to approximate the distribution of Q as a scaled χ2 by matching
the first and second moment of Q with the first and second moments of the χ2 distri-
bution. In particular, the distribution of Q is approximated as κχ2ν , where the scale pa-
rameter, κ, and the degrees of freedom, ν, are calculated via moment matching. Specif-
ically, we define X˜ = [1,X], P0 = I−X˜(X˜′X˜)−1X˜′ for quantitative traits. Then setting
µQ = tr(P0K)/2, Iττ = tr(KP0KP0)/2, Iτσ = tr(P0KP0)/2, Iσσ = tr(P0P
′
0)/2, and
I˜ττ = Iττ −I2τσ/Iσσ, we can subsequenctly estimate κ = I˜ττ/(2µQ) and we can calculate
the p-value for significance by comparing Q/κ to a chi-square distribution of ν degrees
of freedom, χ2ν , where ν = 2µ
2
Q/I˜ττ .
Higher order moment matching
Matching the first and second moment often works well, but in some instances, the
extreme tail probabilities can be poorly estimated. Hence, we may also apply the Liu
et al. (2009) (91) method which comes from matching the third moment of Q and a
scaled χ2 distribution and minimizing the distance between the fourth moments. In
particular, we define
ck = trace((P0K)




where λ1 ≥ λ2 . . . ≥ λm are the m eigenvalues of P0K, and Λ = diag(λl). Then
Q− µQ
σQ
σχ + µχ ∼ χ2ν (2.4)
with µQ = c1, σQ =
√






2µχ, and ν = µχ.
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2.4.6 Further Work on Kernel Machine Testing
Although our focus is on quantitative traits, the overall approach and correspon-
dence with mixed models has been extended to dichotomous traits and to the expo-
nential family (88). Operationally, these methods simply use the working linear model
taken at convergence. The approach has also been extended to analysis of censored
survival gene expression (17) and genetic association (82) studies. Maity et al. (2012)
(101) extended the approach to accommodate multivariate phenotypes. Recently, the
original kernel machine framework has also been directly applied to test rare genetic
variants (141, 8) while Wu et al. (2011) (165) make further methodological contribu-
tions to allow for genome wide sequence data analysis while focusing only on the testing
aspects.
More significant methodological advances include the work of Maity et al. (2012)
(100) who builds on the kernel machine framework to develop an approach for testing
main genetic effects in the presence of interactions. Within the context of rare vari-
ants Lee et al. (2012) (74) develop a test that simulataneously considers linear and
collapsing kernels with analytical p-value formulation while Wu et al. (2012) (163) also
consider the problem of using multiple kernels but develop a computational approach
for evaluating significance. Le et al. (2012) (74) also establish analytical power and
sample size formulae. Schaid et al. (2011) (134) apply the approach within the context
of gene ontology analysis.
Others studying multi-marker analysis (135, 136) have subsequently established
close connections between kernel machine tests and alternative multi-marker tests such
as similarity regression (154, 153, 155) and the global test methods (46, 45). Pan (2011)
(119) shows that the the MDMR test of Wessel and Schork (2006) (159) is equivalent
to the kernel machine test with dichotomous outcomes and without covariates. More
generally, the widely used PERMANOVA approach of McArdle and Anderson (2001)
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(105) can be fit within the context of kernel machine testing.
2.5 Epigenetics
Although the emphasis of our work is on analysis of genotype data and gene-gene
interactions, as noted in the Introduction, as an intermediate step in this project we
develop the additive least squares kernel machine and apply this to methylation data.
Consequently, we briefly describe the principles underlying methylation and the current
state of the art in terms of DNA methylation analysis.
Conrad Waddington was the first to use the term ‘epigenetics’, describing it as “the
branch of biology which studies the causal interactions between genes and their prod-
ucts, which bring the phenotype into being” (47). Historically, epigenetics consisted
of the odd and inexplicable biological phenomena which did not always seem to have
connections. Based on this historical context, the epigenetic phenomenon is thought of
as something that can change the outcome for a locus or chromosome without actually
changing the DNA sequence (47). One of the many unexpected developments for inves-
tigators working with the human genome was the lack of an increase in the number of
genes when examining the complex human structure in comparison to ‘lower species’.
In order to understand this phenomenon scientists have increasingly turned to epige-
netics to find answers to health-related mysteries and clarify the perceived differences
in complexity of different organisms (125).
2.5.1 Current understanding of Epigenetics
Current references to epigenetics denote chemical alterations that occur on DNA or
associated histone proteins that do not alter the DNA sequence, but can change the
structure of chromatin and regulate the readability of genomic regions. Often, these epi-
genetic modifications are heritable and stably transmitted through many cell divisions.
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Modifications of this type can also be reset, feasibly undoing any sort of vicissitudes
they may have induced (125). A formal definition given for modern epigenetics is “the
study of any potentially stable and, ideally, heritable change in gene expression or cel-
lular phenotype that occurs without changes in Watson-Crick base-pairing of DNA”
(47). Under this definition, the molecular mechanisms of genomic reprogramming dur-
ing germ cell specification, embryonic development, somatic cell nuclear transfer, and
therapeutic cloning are epigenetic processes. However, these mechanisms and the effects
they have on certain phenotypes are not well understood. Understanding such systems
is essential as it has been clearly shown that such epigenetic processes are involved
in such disease states as cancer. Already clinical trials of cancer therapies modifying
certain epigenetic processes such as methylation have shown promising results (47).
The field of epigenetics has seen an explosion of research efforts, and as more discov-
eries on the underlying governing processes come to light more questions arise about
the mechanics and molecular actors that play a part in the concepts of epigenetic
heritability and stability. Many of these questions deal with the methods on how epi-
genetic information is propagated through cellular division and differentiation (47).
It is through answering such questions that our understanding of epigenetics and its
effects on various biological mechanisms can be furthered.
2.5.2 Methylation
DNA methylation (DNAm) is one of the oldest known epigenetic modifications and
has become one of the most studied and well known processes within the field. Methy-
lation is characterized in mammals by a chemical modification of chromatin occurring
most often to the cytosine residues of CpG dinucleotides. CpG sites are regions of DNA
where a cytosine nucleotide and a guanine nucleotide occur together in a linear sequence
of bases linked together through a phosphate. By definition, methylation is a covalent
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modification that is both stable and heritable which alters DNA without changing its
sequence. It occurs when a methyl (CH3−) group is added to the fifth carbon of a
cytosine nucleotide, usually a CpG dinucleotide. Areas of the genome which are rich in
CpG dinucleotides are known as CpG islands (CGIs). It is not unusual for regions of
repetitive DNA to be methylated in normal cells for genomic stability as DNAm can
silence parasitic DNA sequences (125). Because of the importance of the role it plays
in many cellular processes, estimates for the number of CpG sites that are methylated
in mammals typically range from 70-80%. Methylation is viewed as a stable, heritable,
and critical component which needs new methods to answer questions and further the
field of epigenetics (47).
The role for DNAm in diseases like autoimmunity, developmental and neurological
disorders, and imprinting and X-chromosome inactivation diseases is not well studied
or understood, although it is generally accepted that it does have a function in such dis-
orders. Other diseases like coronary artery disease, schizophrenia, and some congenital
abnormalities have been shown to have an environmental component which goes hand
in hand with DNAm. Nutritional deficiency during the prenatal stage can lead to inade-
quate establishment of DNAm leading to these disease outcomes. Other environmental
factors like stress or exposure to certain toxins can alter epigenetic components of the
genome leading to certain malignancies. Endocrine disruptors are one of the biggest
environmental factors that humans are exposed to on a daily basis. Fetal exposure to
these disruptors can alter normal methylation patterns resulting in developmental ab-
normalities or adult-onset diseases. The interplay between the environment, genetics,
and epigenetics is crucial in the pathobiology of many conditions or diseases and must
be better understood in order to design better treatments and preventions (125).
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2.5.3 Statistical Analysis of Modern Methylation Data
Extremely limited statistical work has been done within the context of new, large
scale methylation studies which are now possible due to array based technologies (10).
Existing work is largely within the context of older platforms (62, 70). Work on newer
array based platforms has focused primarily on low-level analysis and preprocessing as
well as systematic evaluation of basic biases in the data (148, 11, 152). However, no
consensus has been reached on the best approach low-level analysis.
High-level analysis of array based methylation data has focused primarily on meth-
ods traditionally applied in the gene expression literature. Generally, this involves
testing each CpG on the array, one-by-one, followed by correction for multiple testing.
Pathway and multi-CpG analysis, again using standard methods from the expression
literature, are usually used as a follow up to make results more interpretable and as an
auxiliary analysis when no individual CpGs are significant. However, there are major
differences between new methylation data and classical gene expression work. In con-
trast to traditional gene expression studies which were conducted on a few samples in
controlled environments, methylation studies are often conducted on large, population
studies similar to GWAS. In such observational studies, careful control for confounding
is essential, yet the majority of pathway analysis methods for gene expression analysis
which are being blindly applied to methylation data do not easily allow for covariate
adjustment due to model formulation or to the need to use permutation for significance.
Methods that do allow for covariate adjustment such as the kernel machine test gener-
ally require linearity whereas in reality, many covariates, particularly genomic features,
can be complex and behave nonlinearly or in an otherwise complex manner.
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Chapter 3
Additive Least Square Kernel Machines Regression
3.1 ALSKM Regression in Genome Wide Epigenetic Profiling Studies
3.1.1 Background
The advent of high-throughput biotechnologies has culminated in the development
of large scale “-omic” profiling studies which examine the effects of thousands of “-omic”
features (e.g. genes, SNPs, proteins, CpGs, etc.). Such experiments now form a key
component of modern biomedical research by providing investigators with the necessary
tools to rapidly discover associations between “-omic” features and a range of outcomes.
Although such studies can potentially address many important biological, medical and
public health problems that have eluded researchers for decades, analysis of the data
from large scale profiling experiments has proven challenging. Standard analysis of large
scale experiments often focuses on examining each feature, one-by-one. However, this
approach has been recognized by many as problematic (147, 162). First, the need to
correct for a many multiple comparisons can lead to low power. Alternatively, too many
features can be called significant leading to difficulties in interpretation and formation
of coherent biological hypotheses. Individual feature analysis also fails to allow for
capture of multi-feature or interactive effects. More generally, such approaches have
been found to yield poor reproducibility.
To overcome the problems associated with individual feature analysis, multi-feature
testing, wherein the cumulative effect of multiple typically related features (e.g genes
in a pathway, SNPs in a region, or CpGs in a gene) is tested for association with
the outcome, has become a popular strategy (147, 90, 88). One strategy in particular
that is popular in genomics is the kernel machine regression test which was initially
proposed for gene expression data (90, 88) but has been also extended to the analysis
of SNPs (71, 164) and rare variants (165). Briefly, this approach is built upon a semi-
parametric model within the kernel machine framework (31) in which the effects of
a group of features of interest (e.g. genes in a pathway, SNPs in a region, etc.) are
modeled nonparametrically while some simple confounding covariates are adjusted for
parametrically. A score test is used to test for an association between the outcome
and the nonparametrically modeled group of features while linearly adjusting for the
covariates. A key advantage of the kernel machine framework is the non-parametric
modeling of the multi-feature effects. Our understanding of how -omic features influence
outcomes is deeply limited and there is evidence that using flexible, nonlinear modeling
can allow for better capture of complex and interactive effects and improved power
(164).
An example of a study in which kernel machine regression based testing is useful
is a recently conducted study of child birth weight in which epigenetic profiling of
cord blood from approximately 1000 new-born infants was conducted. In addition to
methylation measurements at 450,000 CpG sites within 20,000 genes, for each subject
in the study, a wide range of potential confounders including demographic variables
and maternal behavior, diet, and environmental exposure data during pregnancy were
collected. The goal was to identify associations between methylation at the gene level
and birth weight while adjusting for the confounding variables. Since each of the genes
contains multiple CpG sites and the outcome is continuous, least square kernel machine
regression is a natural analytic strategy. However, a limitation of current kernel machine
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tests (as well as other multi-feature tests) is that they generally only provide allowance
for parametric adjustment of confounding variables. Yet the covariates are not all well
understood and may affect birth weight in a complex, nonlinear manner. Failure to
accommodate nonlinear or interactive effects can lead to reduced power and inflated
type I error in some cases. New statistical methods are needed for multi-feature testing
while adjusting for complex, possibly nonlinear, confounders.
Motivated by the epigenetic study of birth weight, we propose a new multi-feature
testing procedure that is based on a non-parametric additive least squares kernel ma-
chines (ALSKM) regression model. Specifically, we extend the semi-parametric least
square kernel machine framework of Liu et al. (2007) to allow for nonparametric mod-
eling of both the covariates and the -omic features by setting the outcome equal to the
sum of separate nonparametric functions of the covariates and the -omic features (e.g.
CpGs within a particular gene). We establish a close connection between the ALSKMs
and linear mixed models (LMMs) which can be exploited to enable both estimation
and hypothesis testing within the ALSKM framework via restricted maximum likeli-
hood (REML) and a variance component score test, respectively. The framework shares
the advantages of the previously developed kernel machine tests, but provides further
allowance for sophisticated modeling of the covariate effects allowing for improved pre-
diction and power when covariate effects are nonlinear. We use computer simulations
to verify that our estimation procedure well estimates the nonparametric function and
to examine the power and type I error of the testing procedure. The proposed ALSKM
based test is applied to the motivating epigenetic birth weight study.
Broadly speaking, this project makes important contributions to both applied statis-
tics and to maternal and child health. First, we develop a new multi-feature testing
framework based on the ALSKM framework which provides for improved covariate
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adjustment in -omic studies. Second, we establish connections between LMMs, an es-
tablished classical statistical method, and ALSKMs. This provides a framework by
which we can better interpret an otherwise “black box” machine learning procedure.
Practically, this permits natural strategies for estimation of the nonparametric func-
tions using LMM machinery and testing using a variance component score test. Third,
although our emphasis is on multi-feature testing, the statistical framework we consider
is general and can be used in other applications where it is desirable to model multiple
groups of features (e.g. integrative genomic studies). Finally, we apply our method to
an important genome wide methylation profiling data set to identify new associations
between epigenetic markers and birth weight which has implications in maternal and
child health.
The remainder of this article is organized as follows. In the next section, we describe
the ALSKM framework. In Section 3, we establish the connection between ALSKMs
and LMMs and consider strategies for estimation and hypothesis testing. Simulations
are presented in Section 4. We apply the proposed multi-feature test to the motivating
study in Section 5 and conclude with a brief discussion in Section 6.
3.2 Additive Least Square Kernel Machine Regression
3.2.1 Model and Notation
Suppose that we have a vector of continuous outcomes y = [y1, . . . , yn]
′ and that
z(1) and z(2) are n×p1 and n×p2 matrices of predictors. For instance, z(1) could be the
matrix of confounding variables of interest and z(2) could be the matrix of methylation
levels for the CpGs within a particular gene of interest. For generality, we further let x
denote a matrix of additional variables for which we may like to adjust parametrically.
Then for the ith individual in sample, we related the outcome yi to the predictors
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through the model
yi = xiβ + h1(z
(1)
i ) + h2(z
(2)
i ) + εi (3.1)
where β is a vector of regression coefficients (including an intercept term) and εi has
mean 0 and variance σ2. Each hm(·) (m = 1, 2) is an unknown centered smooth
function.
This model allows for nonparametric modeling of a set of multi-dimensional covari-
ates and also nonparametric modeling of multiple -omic features. Although we allow
for parametric modeling of some additional covariates in x, perhaps some well-studied
predictors, in our setting we restrict x = 1 such that β is just an intercept.
A considerable amount of statistical methodology has been developed in the area
of multivariate and high-dimensional data which will often have both discrete and
continuous variables. Previous work in this area often utilized multi-dimensional non-
parametric models. While there exists a number nonparametric models and methods,
most are not flexible enough to go beyond the context-based problem for which they
were designed. Some such methods include projection pursuit regression, multivariate
kernel smoothing, and many of the spline-based methods which are computationally
expensive and often do not translate well into a multi-dimensional setting (88). It is
evident that further research is needed for fast and robust nonparametric methods and
their implementation. The kernel machine framework provides a natural strategy for
modeling multivariate high-dimensional data. The flexibility that this approach offers
along with connections to linear mixed models make it useful for developing improved
methods in modeling and testing multiple features.
3.2.2 Kernel Machine Modeling of h1(·) and h2(·)
Many of the kernel machine methods that have been developed within the statis-
tical literature have become powerful tools in multi-dimensional data analysis. These
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methods make use of the kernel trick to map complex and possibly infinite dimensional
features into a finite space. This trick uses Mercer’s theorem to define kernel functions
based on whether the function satisfies Mercer’s condition. In satisfying this condi-
tion the kernel function avoids explicitly mapping a complex feature space through
use of the dot product; in this manner, kernel functions can be expressed as an inner
product. The kernel trick also has further implications in dimension reduction since
using an inner product will often result in mapping into a new space. This simplifi-
cation in the specification of a nonparametric model are a part of what makes kernel
machine methods popular in the analysis of multi-dimensional data. Many previous
nonparametric regression procedures generated a basis expansion of derived variables
to perform a linear regression. Such methods include multivariate adaptive regressions
splines (MARS), smoothing splines, additive spline models, and flexible discriminant
analysis (FDA) which is a flexible form of linear discriminant analysis (LDA) (88). By
implementing a kernel function, kernel methods are not necessarily limited to a type
of linear regression. Through the choice of the function, these methods can be applied
to complex and even high-dimensional data. Empirical evidence within the literature
suggests that support vector machines and, more specifically, kernel machines do well
when working in existent learning problems (44).
From an intuitive perspective the kernel function evaluates the covariate vectors
for the ith and i′th subjects. This measures pair-wise similarity (distance) between
individuals in the study, those with a better similarity metric offer an improved ability
to capture the effects of z. Each hm(·) (m = 1, 2) in Model 3.1 is assumed to be a
general function lying in a reproducing kernel spaceHm which is generated by a positive
semidefinite kernel function Km(·, ·) . Under suitable regularity, Mercer’s theorem
(31) implies Hm is uniquely implied by Km(·, ·) and spanned by a set of orthogonal
basis functions φ(z) = {φ1(z), · · · , φJ(z)}, where J is possibly infinite. Then for any
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hm(·) ∈ Hm, hm(z) =
∑J
j=1 ωjφj(z), where ω = {ωj}Jj=1 is a vector of constants. This
form of hm(·) is what is known as the primal representation.
Since J is possibly infinite, explicit specification of φ(·) is often difficult making
working in the primal undesirable. However, the representer theorem of Kimeldorf et
al. (69) allows us to go from the possibly infinite dimensional space of the primal rep-
resentation to a finite space under the dual representation. Specifically, for each hm(·),




l , z) where {α1, ..., αL}
are constants, L is an integer, and {z∗1, ..., z∗L} ∈ Rp. Under the dual, instead of explic-
itly specifying the basis functions, we instead need only to define the kernel function
and estimate the finite vector α.
Choosing the particular kernel enables implicit (rather than explicit) specification of
a complex, nonparametric function space providing a great range of flexibility. A wide
range of kernels have been described in the literature. Some popular kernel functions
include:
• Linear kernel: K(z1, z2) = zT1 z2. The linear kernel is one of the simplest kernel
functions in that it can only pick out lines, or hyperplanes, in the Euclidean space
and essentially assumes that hm(z) = z
′β, a linear function. However, if the data
truly are linear or close to linear then linear kernel often outperforms other more
sophisticated kernels which allow for more complex functional forms.
• dth-order polynomial kernel: K(z1, z2) = (zT1 z2 + c)d where c is a constant and
d is the order of the polynomial. This kernel implies that hm(·) is a polynomial
function of the individual inputs. For instance, when d = 2 (called the quadratic
kernel), hm(z) is implied to be a function of the main effects of the variables in z
as well as their squared and two-way interaction terms.





= is a complex function of radial
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basis with the added tuning parameter ρ which controls the degree of linearity. A
larger ρ forces hm(z) to be approximately linear while a smaller ρ accommodates
highly complex effects.
Many other kernels have been described within the literature and can be tailored to-
wards particular data applications.
3.2.3 Estimation Under the ALSKM Framework
In order to to estimate parameters β, h1(·), h2(·) in Model 3.1 one can maximize
the penalized likelihood, or, equivalently, minimize a penalized sum of squares.










where λ1 and λ2 are tuning parameters controlling the tradeoff between goodness of
fit and complexity. Using the primal representation we can rewrite the maximization
criterion in (5.3) as




yi − xiβ − φ1(z(1)i )Tω1 − φ2(z(2)i )Tω2
}2
− λ1ωT1 ω1 − λ2ωT2 ω2.
(3.3)
This is known as the primal loss function. As noted earlier, this is often difficult to
work with because of the necessity of specifying φ(·). The representer theorem allows
us to go from the possibly infinite dimensional space of the primal representation to a







i , z) = Kmαm (3.4)
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− λ1αT1 K1α1 − λ2αT2 K2α2
and Km is the n× n matrix with (i, i′)th element equal to Km(zi, zi′), called the kernel
matrix.
From the dual representation we can maximize with respect to β, α1, and α2 to
find
βˆ = [xT (I + λ−11 K1 + λ
−1
2 K2)






1 (I + λ
−1
1 K1 + λ
−1
2 K2)
−1(y − xβˆ) (3.6)
αˆ2 = λ
−1
2 (I + λ
−1
1 K1 + λ
−1
2 K2)
−1(y − xβˆ) (3.7)
Substituting this into (3.4) we find explicit expressions for the nonparametric functions
ĥ1 = λ
−1
1 K1(I + λ
−1






2 K2(I + λ
−1




These estimates still require estimation of λ1 and λ2 as well as parameters within
the kernel functions (e.g. ρ for the Gaussian kernel). Generally, this is done using
cross validation, but in the following section, we discuss alternative strategies through
connections with LMMs
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3.3 The ALSKM and Linear Mixed Models
Linear mixed models (LMMs) are a well established statistical method frequently
used for analysis of multivariate and hierarchical data (53, 72). Previous work examined
connections between smoothing splines and LMMs (157, 120). More recently, there
has been considerable work on the connections between LMMs and kernel machine
methods (90, 121). These connections have enabled an improved understanding of
kernel machine methods by placing them within an established, well studied statistical
context. In the general spirit of Liu et al. (2007) (90), we extend these results to
explicitly establish a connection between ALSKMs and LMMs. In addition to improved
understanding, this allows us to use LMM machinery for estimation and hypothesis
testing in the ALSKM framework.
3.3.1 Relationship between ALSKMs and LMMs
In this section, we show that the ALSKM estimator from Model 3.1 corresponds
to the best linear unbiased predictor (BLUP) from a LMM. To see this, we first recall
that the normal equations for the mixed model are given as
X′Rˆ−1X X′Rˆ−1Z








We can set R = (σ2I), Z to be the n × 2n matrix (I, I), where I is the identity
matrix, and G = blockdiag(σ2λ−11 K1, σ
2λ−12 K2). Further setting γˆ as a 2n× 1 vector
γˆ = (hˆT1 , hˆ
T
2 )
T , we see that these normal equations correspond to a mixed model of
the form
y = Xβ + h1 + h2 + e (3.8)
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where β is a vector of regression coefficients, e is the error term, and h1 and h2 are
vectors of subject specific random effects with mean 0 and variance τ1K1 and τ2K2,






. Comparing Models (3.1) and (3.8), we see they
are the same except now the nonparametric functions are treated as random effects.
It follows that the estimates for h1 and h2 are the same when maximizing for the
ALSKM model. We find βˆ = (XTV−1X)−1XTV−1y which is the BLUP for the fixed
effects with a marginal covariance structure of V = σ2I + τ1K1(ρ1) + τ2K2(ρ2). Using
this framework, unknown parameters (σ2, τ1, τ2, ρ1, ρ2) can be estimated using restricted
maximum likelihood (REML). It further follows that the empirical covariance structures








where M = X(XTV−1X)−1XTV−1.
The ability to directly estimate functions and particularly the tuning parameters
as variance components, forgoing computationally expensive cross validation, is a key
result following from the connection between the ALSKM and LMMs. In addition
to estimation, another key advantage lies in being able to run a hypothesis testing
procedure on the nonparametric functions using LMMs, which is described later in this
paper.
3.3.2 Statistical Properties
The estimators for the parameters τ1, τ2, ρ1, ρ2, and σ
2 can be shown to be con-
sistent with a limiting distribution. Consider Θ = [θ1, θ2, . . . , θk] to be a vector of k
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parameters, for this setting k can range from 3 to 5 depending on the type of kernels
used. Let Θ0 be the true value for the parameter Θ. We show that our estimates for
Θˆ = (τˆ1, τˆ2, ρˆ1, ρˆ2, σˆ2) are consistent when Θ0 lies in the interior region or the boundary
of the parameter space Ω. Since Ω is a rectangle of cross products of intervals we know
the parameter space near Θ0 behaves like a closed set indicating the intersection of Ω
and the closure of neighborhoods centered around Θ0 compose closed subsets.
Theorem 3.3.1. Under certain regularity conditions the estimators in Θ for the AL-
SKM are consistent estimators.
When Θ0 lies in the interior region or the boundary of the parameter space Ω, then
we know that our REML estimator, Θˆ, is a consistent estimator for Θ. The regularity
conditions for 3.3.1 are given in Appdendix I along with a proof which follows in the
general spirit of Kim et al. (2012) (68). By using a standard Taylor expansion on the
likelihood at Θ0, we are able to establish Θˆ as a consistent, local maximizer for Θ0.
Theorem 3.3.2. Assuming a
√
n convergence rate then the asymptotic distribution for
the estimator Θˆ is (i) normally distributed when the true parameters are in the interior
points of the parameter space Ω or (ii) a mixture of normal distributions when one
component of the true parameters in Θ0 is a left endpoint of the parameter space.
When the true parameters are in the interior of the parameter space then it is
evident that Θˆ is normally distributed. However, when working on the boundary of
the parameter space, the asymptotic distribution for Θˆ becomes less clear. The usual
arguments for a normal distribution break down here and further work must be done to
determine the true underlying distribution. Starting with arguments originally invoked
by Chant (1974) (20), we are able to extend them to show the asymptotic distribution
for Θˆ is a mixture of normal distributions when on the boundary of the parameter
space. The proof for this distribution on the boundary is shown in Appendix II.
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3.3.3 Multi-feature Testing under the ALSKM
A principle motivation for this work is the desire to be able to test for the effect
of a group of -omic features while adjusting for a set of complex, possibly nonlinear
confounding variables. Without loss of generality, we will assume that we are interested
in testing z(2) adjusting for z(1), though this can be easily reversed.
Noting that y is related to z(2) only through h2(z
(2)), testing for a global effect of
z(2) is equivalent to testing the null hypothesis H0 : h2(·) = 0 in the ALSKM model
(3.1). Using the connection with LMMs, we note that under the corresponding LMM
the corresponding term, h2, has mean zero and variance τ2K2. Hence, an equivalent
null hypothesis is
H0 : τ2 = 0⇔ H0 : h2 = 0. (3.9)
Having brought the ALSKM model to the LMM setting allows us to use the variance
component score test of Zhang et al. (2003) (170) for smoothing splines within a mixed




(y − xβ̂ − ĥ1)TK2(y − xβ̂ − ĥ1).
where σ̂2, β̂ and ĥ are estimated under the null model yi = xiβ+h1(z
(1)
i )+ei via REML
using the connection between the least square kernel machine and LMM established by
Liu et al. (2007) (90).
Note that for kernels such as the Gaussian, K2 depends on an unknown parameter
ρ2 which disappears under the null hypothesis and is therefore inestimable for the score
test. Current machine learning literature dictates that when ρ is inestimable it can be
held constant at a reasonable value, typically determined by previous studies or expert
opinion. As a score test, the procedure is valid for any value of ρ2 (specified without
regard to the outcome variable), but better values can lead to improved power.
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Developing a testing procedure for our null hypothesis in (3.9) is challenging since
0 is on the boundary of the parameter space. Without strong conditions on the co-
variance matrix in the LMM formulation (which is often not possible due to the com-
plexity of the kernels), we can no longer assume that Q follows a mixture χ20/1. In-
stead, Q follows a complex mixture of χ2 variables. Thus, in order to obtain the
null distribution, and hence a p-value, we instead use the Satterthwaite method to
approximate the null distribution of our test statistic as a scaled chi-square distri-

















, and Iσ2σ2 =
P20
2
. Under the null hypothesis the projection










We considered several simulation scenarios to examine the prediction accuracy of
the ALSKM procedure using the LMM connection to estimate model parameters and
functions. For all scenarios, we conducted 1000 simulations with a fixed sample size
of n = 200. Data for elements of z(1) and z(2) were simulated from independent uni-
form(0,1) distributions with p1 = p2 = 5. Outcomes for each scenario were simulated
using the model yi = h1(z
(1)
i ) + h2(z
(2)
i ) + ei, where ei ∼ N(0, 1).
For different scenarios we considered both linear and nonlinear structures for h1 and
h2. Specifically, we let
h1(z
(1)
1 , ..., z
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under the linear setting. Scenario 1 uses these two linear structures to simulate data.
Non-linear data structures are
h1(z
(1)
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Scenario 2 uses a linear equation for h1 and the above non-linear equation for h2 while
scenario 3 uses both of the non-linear equations to simulate data for h1 and h2.
For each scenario, which is defined based on the choice of h1 and h2, we applied the
ALSKM based on REML optimization to each simulated data set. The kernel functions
were set to be linear, quadratic, or Gaussian, but we restricted the type of kernel to
be the same for both h1 and h2 for simplicity. For each data set, prediction error was
measured on an external test set of 500 individuals for each simulation.
The average prediction error is given for all the kernels under each setting in Table
3.1. The linear and non-linear functions for h1 and h2 from each of the scenarios were
used to examine prediction error for each of the kernels as the true underlying data
goes from being linear to partially linear to completely non-linear. As anticipated,
the linear kernel performed well, in terms of prediction, when the true underlying
functions were both linear. When moving into a non-linear setting the prediction
accuracy diminishes significantly. In contrast, both the Gaussian and quadratic kernels
maintained approximately the same level of prediction accuracy across all simulation
scenarios – not as good as the linear kernel when h1 and h2 are linear, but offering
improved prediction accuracy over the linear kernel when effects are non-linear. The
extra parameters for the Gaussian kernels ρ1 and ρ2 were estimated in the covariance
for the REML model.
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3.4.2 Score Simulations
We evaluated the type I error and the power of our score test using simulations. Data
for these simulations were generated under the same linear and nonlinear structures
given in the prediction and estimation section, but this time we indexed the importance
of h2 using a parameter a. Specifically, we set yi = h1(z
(1)
i ) + ah2(z
(2)
i ) + ei where a
ranges from 0 to 1 and adjusts the amount of signal coming from h2. The signal grows
stronger as a increases; when a = 0 we are working under the null hypothesis.
Simulations under varying kernels for different structures for h1 and h2 indicated
that the score test was not greatly affected when the kernel function for h2 was mis-
specified. However, under non-linear settings when h1 was incorrectly specified to lie in
a linear function space, we found a significant loss in power. Similar results were found
when using comparable testing procedures which places an actual linear structure on




i ). Figure 3.1 shows the result for
the linear setting as the signal, drawn along the x-axis, increases. The figure indicates
a loss in power when K1 is misspecified as quadratic when we are in fact working in
a linear space. This, however, does not seem to be a problem for the Gaussian kernel
as ρ1 can be estimated to render the kernel more linear in nature. When testing the
Gaussian kernel under varying values for ρ2 ranging from 1 to 10,000, we found very
little variation in the outcome except when the kernel lacked regularity with gross mis-
specification of ρ2 to be 1. By raising this to be a more reasonable level of even 5 we
see the lack of regularity disappear and results seem to remain similar over the rest of
the range that was tested for ρ2. The figures given below show results when ρ2 is held
constant at 100. This was chosen arbitrarily because it does not lie on either extreme
and was neither the best nor the worst performer in our trials.
Figure 3.2 shows the same results under the non-linear data setting where the true
underlying function for h1 is cubic and h2 is quadratic. There is a large drop in power in
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all cases where the kernel for h1 is misspecified to be linear. This is similar to what was
seen in Figure 3.1 when a quadratic kernel is misspecified for a linear h1. As indicated
in the first row of Figure 3.2, there is minimal difference in error and power for different
specifications of K2, even when it is misspecified for the true underlying h2 function.
3.5 Application to Motivating Study
We applied our new multi-feature score test based on the ALSKM procedure to a
motivating data set examining the relationship between CpG methylation in cord blood
and child birth-weight.
Birth weight is known to be an important measure of a child’s juvenile and adult
health. In particular, a child’s birth weight has been related to subsequent development
of adverse health outcomes such as obesity, diabetes, cardiovascular disease, asthma
and others (143, 140). Hence, it is of considerable interest to understand which genes
exhibit epigenetic changes that are related to birth weight since such information could
provide intimate clues toward the epigenetic basis of birth weight regulation.
To study this topic, a recent study was conducted in which child cord blood was
collected from n = 1046 singleton live births. All subjects were of northern European
descent. Epigenetic profiling of 485,000 CpGs across the genome was performed on each
of the cord blood samples. Briefly, the methylation level of each CpG is a continuous
measurement between 0 and 1. In addition to epigenetic information, a wide range of
dietary, behavioral, demographic, and environmental exposure variables were collected.
The goal was to identify CpGs with methylation levels that are related to birth weight
while adjusting for the non-epigenetic variables.
We applied the proposed ALSKM based multi-feature test to identify genes (each
containing multiple CpGs) that are related to birth weight while adjusting for pos-
sible complex confounders including maternal age, parity, dietary and serum folate,
52
gestational age, cotinine (smoking), maternal education, and preeclampsia. Some of
these confounders are known to affect birth weight non-linearly. The CpG sites can be
mapped into approximately 20,000 genes which are treated as a group for the testing
procedure. Each gene (group of CpGs) was then tested for an association with birth
weight while adjusting for confounders. We modeled the joint effect of the confounders
as well as the effects of the CpGs in each gene using the ALSKM framework with a
linear, two-way interaction (100), and Gaussian kernel. The overall type I error rate
was controlled at the 0.05 level using a Bonferroni correction.
The number of genes called significant using each combination of kernel for the
confounders (K1) and the kernel for the CpGs (K2) are given in Table 3.2. Covariates
were modeled in h1 which is defined based on K1 and the CpGs were modeled in
h2 which is defined based on K2. Using the Gaussian kernel for testing the CpG
groupings tended to result in more genes called significant than using the linear or 2-
way interaction kernels. Using a linear kernel for the adjusting covariates consistently
found the fewest number of genes, which is consistent with our previous results. Further
detailed examination of the results and validation will be conducted and the specific
genes called significant will be presented elsewhere.
3.6 Discussion
Motivated by a real data set, we generalize the previously developed semi-parametric
least square kernel machine score test to allow for flexible, possibly non-parametric
modeling of confounders for which we would like to adjust. Specifically, we explore the
ALSKM framework and draw parallels with random effects models and REML to take
this machine learning methodology into a statistical framework. This further allows
for easy implementation using mathematical software. Our proposed procedure allows
researchers to test for complex multi-feature effects while simultaneously adjusting for
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other factors that could also lie in a complex, non-parametric space. Simulations and
real data applications suggest that the proposed method offers advantages over the
previously developed kernel machine based multi-feature tests which require parametric
specification of the covariate effects.
The choice of the kernel function for K1 is vital when the features going into h1
are nonlinear. Results from the score test simulation indicate that the assumption of
linearity in a model when the adjusting variables do not follow a linear pattern can
sometimes lead to adverse results, with an inflated type I error and reduced power.
Misspecifying K2 seems to have far less dire consequences as the power of the score
test results seemed more robust to this error. These results indicate that our non-
parametric testing procedure offers improvements over its semi-parametric counterpart
as the semi-parametric test automatically places a linear structure on the adjusting
covariates that we place into h1. Further work is needed to identify specific kernels
that can work well under particular scenarios. It is clear that in order to be able to
correctly test for significance in complicated, high-dimensional data settings the testing
procedures must be able to accommodate for complex structures in both the adjusting
and main effects.
Although emphasis in this paper is on using two additive functions, the framework
is easily extended to accommodate more than two functions. Furthermore, while we
focused on modeling a single group of -omic features and a group of covariates, the
frame work can also be used to jointly model data from diverse -omic experiments, a
recent trend in the genomic literature. Further exploration of such extensions is needed.
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Figure 3.1: Scenario 1, Linear h1 and h2





















































































Figure 3.2: Scenario 3, non-linear h1 and h2 data structures





















































































Table 3.1: Mean Prediction Error
Scenarios for Kernels
h1 and h2 Linear Quadratic Gaussian
Scenario 1 1.06 1.17 1.18
Scenario 2 1.39 1.17 1.20
Scenario 3 20.04 1.58 1.47
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Table 3.2: Birth weight methylation study results
Kernel for Kernel for CpG Effects (K2)
Covariates (K1) Linear 2-Way Interaction Gaussian
Linear 62 55 62
2-Way Interaction 66 58 67
Gaussian 63 59 65
Covariates were modeled in h1 which is defined based on K1
CpGs were modeled in h2 which is defined based on K2
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Chapter 4
Testing Gene-Level Epistatic Interactions with SKIT
4.1 Introduction
Over the last several years, genome-wide association studies (GWAS) have mapped
thousands of genetic variants associated with complex diseases and disease-related
quantitative traits (57, 56). However, to date most mapped variants contribute only a
modest proportion of the underlying heritability for most traits (102, 99, 40), suggest-
ing that many additional trait loci are still to be discovered. A general hypothesis for
why many trait loci have yet to be identified is that the standard GWAS paradigm for
gene mapping of complex traits, which employs individual testing for the main effects
of individual common single-nucleotide polymorphisms (SNPs) across the autosomes,
may be too na¨ıve for reliable gene identification. One particular limitation of current
methodology lies in the identification of gene-gene interactions, or epistasis. Epistatic
relationships (29) may explain some of the missing heritability (173) and can account
for replication failures of initial GWAS findings(60, 49).
Despite some success in identification of gene-gene interactions for Crohn’s disease
(41), autism (93), and multiple sclerosis (16), powerful analysis of epistatic effects con-
tinues to pose a major challenge for the field. Currently, standard examination of
epistatic effects involves using a regression model accounting for the main effects of the
genotypes of two single nucleotide polymorphisms (SNPs), and also the 2-way interac-
tion between the two SNPs. One can then test whether the regression coefficient for the
interaction is different from zero. Such analyses are often applied to candidate SNPs,
e.g. those lying within particular pathways or with significant main effects, and can
also be applied exhaustively, though the computation quickly becomes prohibitively ex-
pensive and the threshold for statistical significance, extremely stringent. In addition,
this form of analysis suffers from reduced power when the causal SNPs are not geno-
typed (124) and also fails to accommodate more complex interaction effects involving
multiple pairs of SNPs or higher order interactions.
Many of the problems related to analyzing epistatic effects on the SNP-by-SNP scale
are analagous to the difficulties faced by using individual SNP analysis, wherein each
SNP is examined one-by-one, for testing the main effects of SNPs. SNP-set testing is
a common way of bypassing many of the limitations associated with individual feature
analysis within the context of studying main SNP effects. SNP-set analysis focuses on
simultaneous analysis of multiple SNPs, which are grouped based on prior knowledge
into a SNP-set, and assessing the cumulative effect of SNPs in the SNP set on a trait.
Common grouping structures include grouping all features associated with a gene (e.g.
all SNPs within the gene), within a pathway, or within some functional group. SNP-
set analysis allows for reduced multiple comparison burden and facilitates detection
of multi-SNP effects. At the same time, it allows for improved gene mapping when
the causal SNP is untyped but in modest linkage disequilibrium (LD) with multiple
genotyped SNPs. Although SNP-set analysis has been found to be a powerful approach
for analysis of main SNP effects, relatively little is available for interrogation of epistasis
within the context of multi-SNP analysis.
In this paper, we propose the SNP-set kernel interaction test (SKIT), a novel ap-
proach for epistasis testing using SNP sets in quantitative trait studies that considers
60
an interaction on the scale of multiple SNPs, rather than on the scale of a single SNP,
by testing for interactions across two different SNP sets, e.g. comprised of SNPs from
two different genes. Specifically, we will use the powerful kernel machine regression
(KMR) framework which has become a popular method for main effect testing of com-
mon (71, 161, 83, 101) and rare variants (165, 74) and been successfully applied to many
studies (86, 92, 98, 142, 95). Under the KMR framework, pair-wise similarity between
individuals in terms of genotype, measured through a kernel, is compared to pair-wise
similarity in phenotype with correlation indicative of association. SKIT extends this
to allow for testing of interactions by comparing pair-wise similarity in the interaction
effects to pair-wise similarity in the phenotype while adjusting for main effects.
Similar to the main effects testing setting, SNP-set modeling of interactions has
several advantages over single SNP-based modeling. Modeling multiple SNPs in a
gene together should tag untyped causal variants better than individual SNPs, but our
procedure will have fewer degrees of freedom than an analogous haplotype test, and
thus be more powerful. Furthermore, assuming a commercial panel of 1 million SNPs
that help tag ∼22,000 genes, exhaustive pairwise gene-based interaction testing using
kernels should potentially be more powerful (owing to a less stringent multiple-testing
adjustment) and more computationally efficient than exhaustive SNP-based interaction
testing, since the former requires approximately 2000-fold fewer tests than the latter for
analysis. In addition to the gene-based nature of the interaction test, KMR methods
have many other attractive features for practical analysis that other methods lack. For
instance, KMR allows for covariates, adjusts for LD among variants, and allows for
rapid, analytic p-value computation.
The remainder of this article is organized as follows. In the next section, we describe
the SNP-set kernel interaction test, first under a simple linear model and then under
the general KMR framework. We then present simulation results comparing the SKIT
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to alternative SNP-set based tests of epistasis as well as an application to a genetic
association study of birth weight. We conclude with a brief discussion.
4.2 Methods
4.2.1 SNP-Set Kernel Interaction Test
For simplicity, we describe our approach for testing interactions between two differ-
ent SNP sets on a quantitative trait by considering only a single pair of SNP-sets with
the understanding that the approach can be applied to multiple pairs of SNP-sets with
appropriate control for multiple comparisons.
In this paper, we assume that a population-based quantitative trait mapping study
was conducted in which n individuals are genotyped. Our approach assumes that
the SNPs of interest have been grouped according to prior biological knowledge, such
as proximity to a gene or another genomic feature. Then for two different SNP sets




i denote the vectors of
SNP values (coded as 0, 1, and 2 for the minor allele) for the SNPs in each SNP set
for the ith individual in the study (i = 1, . . . , n). We let zi represent the full vector
of SNP values for both SNP-sets. The quantitative outcome for the ith subject is
denoted by yi. We further assume that for each individual we have an additional set
of m demographic, environmental, or other confounding covariates collected which are
denoted as xi1, . . . , xim. The objective is then to test for the effect of the interaction
between the SNPs in the first SNP set and the SNPs in the second SNP set on the
quantitative trait value while adjusting for the main effects of the SNPs in each SNP




We first describe the SKIT under a simple model in which the outcome depends on
only the 2-way interactions between the SNPs in the SNP sets and in which the main
effects of each SNP set are simple, i.e. no interactions within the SNP sets.





i , and their 2-way interactions is through the linear model



















γj1j2 + εi (4.1)
where α0 is an intercept, εi is an error term with mean zero and variance σ
2. α, β(1) and
β(2) are the vectors of regression coefficients for the confounders, the main SNP effects
for SNP set 1, and the main SNP effects for SNP set 2, respectively. The regression
coefficient for the interaction between the j1 SNP in the first SNP set and the j2 SNP
in the second SNP set is given by γj1j2 .
Testing for the interaction effects corresponds to testing the null hypothesis that
each γj1j2 = 0 for all j1 = 1, . . . , p1 and j2 = 1, . . . , p2. In principle, this can be done
by using the usual likelihood ratio test. However, there are two difficulties. First, this
has low power as it requires a p1 × p2 degrees of freedom test. Second, estimation of
β(1) and β(2) is challenging since p1 and p2 can be high dimensional and because there
is the potential for strong LD.
To overcome the first difficulty, we can apply a similar approach as SKAT (165) and
assume that each γj1j2 follows an arbitrary distribution with mean zero and variance
τ . Then testing whether all of the γj1j2 = 0 is equivalent to testing the null hypothesis
H0 : τ = 0 which is easily done via a variance component score test. Specifically, we
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can construct the score statistic:
Q =
(y − α̂0 −Xα̂− Z(1)β̂(1) − Z(2)β̂(2))′K(y − α̂0 −Xα̂− Z(1)β̂(1) − Z(2)β̂(2))′
σ̂2
(4.2)
where α̂0, α̂, β̂
(1), β̂(2) and σ̂ are each estimated under the null model in which the
trait value does not depend on the interactive effects. The “kernel matrix” K is an
n × n matrix with (i, i′)th element equal to ∑p1j1=1∑p2j2=1 z(1)ij1 z(1)i′j1z(2)ij2 z(2)i′j2 . Typically,
estimation is done using least squares regression; however, the second difficulty still
poses a challenge. Therefore, we also follow the strategy of Lin et al. (84) and choose
to set β̂(1) and β̂(2) to be the ridge regression estimates for β(1) and β(2), respectively.
Under the null hypothesis, Q asymptotically follows a mixture of χ21 distributions
which can be approximated using moment matching (91) or exact methods (34, 38)
allowing for rapid p-value computation. These approaches naturally adapt the degrees
of freedom of the test based on the correlation between the interaction effects: under
the most extreme case in which the SNPs within each SNP set are in perfect LD, such
that the interactions are perfectly correlated, then the test reduces to a single degree
of freedom test.
Kernel Machine SKIT Model
Testing using kernel machine regression (KMR) approaches (90, 88) has recently
become a common mode of analysis for testing the joint main and interaction effects
of a group of genetic variants. In this section, we describe an extension of the kernel
machine regression framework to test specifically for interactions between SNP-sets.
Under the KMR framework for SKIT, we allow for increased flexibility in the rela-
tionship between the SNPs in the SNP-sets (both main effects and interactions) on the
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trait value. Specifically, we use the general nonparametric model
yi = α0 + x
′
iα+ h(zi) + εi (4.3)
where α0, α, and ε are as before. h(·) is a generally specified, unknown, possibly
nonparametric function of the genetic variants. The trait now depends on the effect of
the SNPs in the SNP sets. However, h(·) is a function of both the main effects as well
as the interactions. Equation (4.3) can be given a more flexible form using an additive
KMR model with three additive functions:
yi = α0 + xiβ + h1(z
(1)
i ) + h2(z
(2)
i ) + hix(zi) + εi (4.4)
Here, h1(·) depends only on the main effects of the first SNP-set (z(1)) alone, h2(·) on
the main effects of the second SNP-set (z(2)) alone, and hix(·) depends only on the
interactions between z(1) and z(2). In general, nonparametric regression with multi-
dimensional data is challenging; however, SKIT exploits recent advances in kernel ma-
chine regression (KMR) approaches (31) to facilitate complex modeling. Then (4.4)
can be treated as an additive kernel machine model (26).
Under the KMR framework, h(·) in (4.3) is a function lying within a reproducing
kernel hilbert space H generated by a corresponding kernel function K(·, ·). The kernel
matrix K is a matrix with the (i, i′)th element equal to K(zi, zi′). Intuitively, the kernel
function evaluates the similarity between vectors of covariates for the i and i′th subjects,
in this case, based on the SNPs in both SNP sets and their interactions. Mathematically,
the kernel function inherently determines the form of the function h(·): if we choose the
“linear kernel” and set K(zi, zi′) = z
′
izi′ , then this implies that h(zi) = β
′zi, i.e. that
h(zi) is a linear function of the input variables. Choosing a different kernel function
implies that we are choosing a different, possibly more complex model including those
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that accommodate nonlinear effects or interactions. For example, if we instead choose
to use the “quadratic kernel” and set K(zi, zi′) = (z
′
izi′ + 1)
2, then this implies that
h(zi) is a function of the main effects of the SNPs in zi as well as their squared effects
and their pairwise, 2-way interactions. More sophisticated kernels can lead to even
more complex models.
The linear and usual identity-by-state (IBS) kernels are useful for modeling main
SNP effects but are not directly useful within this framework as they do not di-
rectly model interaction effects. Beyond the quadratic kernel, other kernels that are
useful within the context of interaction testing include the 2-way interaction kernel
and the squared IBS kernel. The 2-way interaction kernel is defined as K(zi, zi′) =
z′izi′ +
∑
1≤j<k≤p zijzi′jzikzi′k which implies that h(zi) is a function of the main effects
of the SNPs as well as their 2-way interactions. The squared IBS kernel is defined
as K(zi, zi′) =
(∑p
j=1 IBS(zij, zi′j) + 1
)2
where IBS(zij, zi′j) is the number of alleles
at the jth SNP shared identical by state. Other kernels that are not additive in the
individual SNPs will capture interactions and can be used here as well.
Similar to h(·), each h?(·) (with ? equaling 1, 2, or ix in turn) lies within a corre-
sponding functional space H? generated by a kernel function K?(·, ·) with kernel matrix
K? and α0 as the intercept term.
Kernel Machine SKIT Procedure
Since the outcome depends on the interactions only through hix(·), then testing for
an interaction corresponds to testing the null hypothesis
H0 : hix(z) = 0 (4.5)
66




i ) and the covariates, such that under
the null, (4.3) becomes




i ) + h2(z
(2)
i ) + εi. (4.6)
Assuming that we can identify appropriate kernel functions for each of h1(·), h2(·)
and hix(·), then we can exploit the score test developed by Clark et al. (2012). The
approach exploits the close connection between linear mixed models and kernel machine
methods to allow for testing (4.5) by constructing the score statistic
QKix =
(y − α̂0 − xα̂− ĥ1(z(1))− ĥ2(z(2)))′Kix(y − α̂0 − xα̂− ĥ1(z(1))− ĥ2(z(2)))
σ̂2
(4.7)
where each of α̂0, α̂, σ̂, ĥ1(z
(1)), and ĥ2(z
(2)) are estimated under the null model (4.6).
This can be done via maximization of the penalized likelihood function




yi − α0 −αxi − h1(z(1)i )− h2(z(2)i )
}2




Where λ1 and λ2 are tuning parameters controlling the tradeoff between goodness of fit
and complexity. For fixed values of λ1 and λ2, closed form estimates for the parameters
are available as
αˆ = [XT (I + λ−11 K1 + λ
−1
2 K2)
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Tuning parameters λ1 and λ2 can be estimated as variance components using restricted
maximum likelihood (REML) and exploiting the relationship between additive KMR
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methods and LMMs. Alternatively, one may consider a fine grid of values and minimize
the generalized cross validation statistic (GCV).
As with the linear SKIT scenario, under the null QKix follows a mixture of chi
squares which can again be approximated using moment matching procedures or exact









0 and P0 = V
−1−V−1X(X′V−1X)X′V−1, here V = σ2(I+λ−11 K1+λ−12 K2),
is the projection matrix under the null additive KMR model.
A fundamental assumption is that we can find appropriate kernels for each of the
functions. Identification of kernels that can be used for h(·), h1(·) and h2(·) is straight-
forward. However, identification of a kernel for hix(·) is more difficult. In particular, it
is generally challenging to obtain a kernel function which depends solely on the inter-
action effects without also including the main effects. Intuitively, the difficulty arises
because the SKIT compares pair-wise similarity between subjects in terms of their in-
teractions to pair-wise similarity in phenotype. Practically, it is difficult to compute
similarity in the interaction without also including similarity in the main effects. For
example, if we set Kix to be the quadratic kernel, then this would imply that hix(z)
would be a function of the main effects and squares of the main effects, in addition to
the two-way interactions. Outside of a few simple kernels such as the linear kernel, first
computing the two-way interactions and then modeling them would still result in the
main effects contaminating the desired interaction effects and could prevent detection
of higher order interactions. An alternative approach is necessary.
Interaction Kernels
Given the difficulties associated with directly specifying and constructing a kernel
function for the interaction terms, we develop an alternative approach for approximat-
ing the kernel matrix for the interaction terms based on (i) utilizing the kernel functions
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that can be easily specified, (ii) obtaining a finite sample approximation of the bases for
the functional spaces corresponding to the specified kernels (iii) then using differences
between the approximate bases of the specified spaces to identify an approximate kernel
basis for the space spanned by hix(·). More specifically, we know by construction that
HK = H1 +H2 +Hix such that Hix = HK −H1 −H2. We then take our approximate
bases for HK ,H1,H2 to generate an approximate basis for Hix. This approximate basis
can be used to approximate the interaction kernel matrix Kix for the score test.
Given K we can generate an empirical basis for HK by applying kernel principal
component analysis (KPCA) to K (138). In particular, we let U denote the eigenvectors
of K and Λ = diag(λ1, . . . , λn) where λ1, . . . , λn are the eigenvalues. Similarly, we let
U1 = [u11 , . . . ,u1n ] denote the eigenvectors for K1 and U2 = [u21 , . . . ,u2n ] denote the
eigenvectors of K2 and Λ1 and Λ2 are the corresponding matrices with the eigenvalues
of K1 and K2 on the diagonal. We can then generate an approximate basis for HK as
Φ̂ = [φ̂1, . . . , φ̂n] = UΛ
1/2. Similarly, approximate bases for H1 and H2 are estimated
as ξ̂ = [ξ̂1(z
(1)), . . . , ξ̂n(z
(1))] = U1Λ
1/2
1 and η̂ = [η̂1(z




In order to identify the approximate basis for Hix, say Ψ̂ = [ψ̂1(z), . . . , ψ̂n(z)], we
compute the orthogonal projection of Φ̂ onto the space spanned by ξ̂ and η̂, H1 +H2.
Using augmented the matrix M = [ξ̂, η̂], we can estimate Ψ as
Ψ̂ = Φ̂− projMΦ̂
= Φ̂−M(M′M)−1M′Φ̂
Since Ψ̂ forms an empirical basis, we can generate Kix = Ψ̂Ψ̂
′. Minor adjustments
may be necessary to ensure that columns of [ξ̂, η̂] are not linearly dependent.
Once we have obtained Kix, we can directly use the earlier KMR SKIT score test
to assess the epistatic effects of z(1) with z(2). Note that since KPCA needs to be
69
used, one can choose to estimate the main effects of the SNPs in the SNP set by
using ridge regression with ξ̂ and η̂ as covariates as an alternative, equivalent strategy
to optimization of (4.8). This alternative works very well in linear cases. As the
the setting becomes more complex, though, the linear assumption can be problematic
making the non-linear SKIT a more viable option.
4.2.2 Existing SNP-Set Based Interaction Tests
Although other existing SNP-set based tests of epistasis could be used for evaluating
the interactive effect between two different SNP-sets (78, 54, 124, 94), SKIT offers a
number of advantages over these existing methods, particularly since many methods
cannot correctly control type I error under different scenarios – leading to excessive
false positives – and because SKIT offers improved flexibility. Here, we briefly discuss
some alternative tests that fall into a few different categories.
A major class of SNP-set based tests of epistasis encompasses the methods that are
based on examining the interaction between each of the p1 SNPs in the first SNP-set and
each of the p2 SNPs in the second SNP-set, one-by-one (94). Some of these methods rely
on exhaustively testing the two-way interaction effects of each pair of SNPs and then
taking the minimum of the p1×p2 p-values. Then corrections are made for having taken
the minimum p-value, while accommodating for LD, by using normal approximations
or by computing the effective number of interaction tests (112). Alternatively, the top
p-values from each of the p1 × p2 tests can be combined. Overall, this class of test
still strongly relies on testing the individual pair-wise interactions. Since they do not
directly borrow information across SNPs that are frequently correlated, they are likely
to lose power when individual SNPs are not in high LD with the causal interactions.
Furthermore, such tests cannot accommodate complex interactive effects. Finally, these
methods often lead to increased false positives if main effects are also present since the
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mean models are not well captured. Our simulations will verify that the SKIT can offer
improved type I error control while still having higher power in many scenarios.
A second major class of methods are based on constructing a weighted average of
the SNPs within each SNP-set and then testing for interactions using the averaged vari-
ables. Common weights include principal component analysis (PCA) or weighted PCA
methods (78, 54, 94). These methods are limited in that the principal components are
constructed without regard to the outcome and are do not allow for optimal weighting
— this is in contrast to SKIT which uses a supervised regression based approach. Also,
PCA based methods cannot correctly control type I error when there are both main
effects as well as interaction effects again due to loss of homoskedasticity and inability
to correctly capture the mean model.
Alternative methods (124) focus primarily on dichotomous traits and are not easily
applied to quantitative traits. Some methods also rely on the use of permutation which
causes problems in the case of interaction analysis: because the interaction effects of
the SNPs are necessarily correlated with the main effects, standard permutation is not
valid since it breaks the correlation and violates the exchangeability requirement. This
again leads to inflated type I error, even in the case when neither the main effects nor
the interactions are related to the outcome.
4.2.3 Simulations
We evaluated the validity of the proposed SKIT method as well as several existing
methods by conducting simulations to examine the type I error and power under a
range of scenarios.
For both the type I error and power simulations, we first used the HAPGEN2 geno-
type simulator (103, 146) to simulated data from the SPARC gene and the ASAH1
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gene based on HapMap2 CEU data. In particular, we simulated genotype informa-
tion for 20,000 subjects and then bootstrapped from this pool to generate data sets
containing n individuals. The SNPs within each separate gene were grouped to form
separate SNP-sets: we let sASAH1i and s
SPARC
i denote the vectors of genotype values for
the SNP-set based on the ASAH1 and SPARC genes, respectively, for the ith simulated
subject. For each data set, we simulated two covariates for each of the n individuals
as xi1 ∼ N(29.2, 445.2) and xi2 ∼ Ber(0.506). The genotype at the two different genes
and the covariates were then used to generate outcomes yi for each subject. Impor-
tantly, since the genotyped variants in a genetic association study generally represent
only a small subset of the variants, we then let zASAH1i and z
SPARC
i denote the values of
the SNPs in sASAH1i and s
SPARC
i , respectively, which are genotyped on the the Affymetrix
500k SNP array. While any of the SNPs in sASAH1i and s
SPARC
i may influence the outcome,




Type I Error Simulations
To examine type I error, we considered four different null scenarios in which the
outcome does not depend on the interactions between the SNPs in SPARC and the
SNPs in ASAH1. Specifically, under Scenario A, we simulated outcomes under a model
in which the outcome does not depend on the SNPs in the SNP sets at all:
yi = 0.03xi1 + 0.5xi2 + εi
where εi ∼ N(0, 1).
Under Scenario B, we allowed the outcome to depend on a single (typed) variant in
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ASAH1 and a single (typed) variant in SPARC:





Although the outcome does depend on the main effects of the SNPs in the SNP-sets,
this is still a null model since the outcome does not depend on the interactive effects.
Scenario C is similar to the previous scenario in that the outcome is allowed to
depend on main effects, but here it depends on only a single variant from in the ASAH1
gene:
yi = 0.03xi1 + 0.5xi2 + s
ASAH1
i,44 + εi.
Scenario D differs from the other scenarios in that we now allow for strong epistatic
effects within each SNP-set:















Note that the epistatic effects are internal to the separate SNP-sets rather than across
SNP-sets such that we are still under the null.
Under each scenario, we consider sample sizes of n = 500, 1000, and 1500 individu-
als. Then for each scenario and sample size, we simulated 50,000 data sets. We applied
the linear SKIT as well as SKIT under each of the 2-way interaction, quadratic, and
squared IBS kernels to each data set to test for an interaction between the SNPs in
ASAH1 and SPARC while adjusting for the covariates. Recall that we treated only
the SNPs in zASAH1i and z
SPARC
i as observed. For each method under each scenario and
sample size, the type I error was estimated as the proportion of p-values less than 0.05.
In addition to the proposed SKIT methods, we also considered the type I error of
several competing methods described and implemented by others (94). Specifically, we
considered the minimum p-value (minP), GATES, tail strength, product p-value, and
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PCA based averaging methods. The minP approach operates by exhaustively testing
the pair-wise interactions between each pair of SNPs across the two SNP-sets, and
then adjusting for having taken the minimum using an approach that accommodates
the correlation between p-values (28). The GATES method for interactions is similar
to the minP method in that it focuses on taking the minimum p-value, but uses a Simes
type method with the effective number of tests. The tail strength and product p-value
approaches are extensions of the minimum p-value based methods that uses not only
the smallest p-value, but also additional p-values less than some threshold. Finally,
the PCA based averaging method operates by using the principal components for each
SNP-set capturing 90% of the variability to reduce the dimensionality of each set. All of
the PCs for both SNP-sets as well as the pairwise interactions between the PCs across
SNP-sets are included in a model and the interactions are assessed via a likelihood ratio
test. Each competing method was also applied to the genotyped variants and type I
error was also estimated at the 0.05 level.
Power Analysis
Power simulations were run for both the proposed SKIT methods and for the com-
peting methods using a similar setup as for the type I error simulations. However, here
the outcome was simulated under alternative models.
As noted earlier, and verified in the type I error simulation results, many of the
competing methods fail to control the type I error rate when there are main effects
present. Therefore, all power simulations are done under scenarios in which the outcome
depends only on the interaction effects between SNP-sets and not on the main effects
of the SNPs in the SNP-sets.
We first consider the scenario in which we have a single interaction between a variant
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in ASAH1 and a variant in SPARC. Specifically, we simulate outcomes using the model




where c1 and c2 are the indices of the causal SNPs in the ASAH1 and SPARC genes,
respectively, and may not represent genotyped SNPs. We consider three different sce-
narios. Under Scenario E, we set c1 = 1 and c2 = 1 such that the causal SNPs in
ASAH1 and SPARC are rs7508 and rs3549. Neither causal SNP is genotyped. Under
Scenario F, we again set c1 = 1 but let c2 = 32 such that the causal SNP in SPARC
is rs725937 which is considered to be genotyped. Under Scenario G, we now let both
causal SNPs bet genotyped by setting c1 = 44 and c2 = 10 such that the causal SNPs
in ASAH1 and SPARC are rs35573135 and rs1864964.
Under each of scenarios E through G, we considered sample sizes of n = 500, 1000,
and 1500. Then for each scenario and sample size we simulated 500 data sets. We
applied the linear SKIT and SKIT under each of the 2-way interaction, quadratic, and
squared IBS kernels. In addition, we also applied the competing minP, tail strength,
p-value product, and PCA based methods to each data set. Note that the GATES
method for interactions may not control type I error correctly and is therefore not
considered. Further note that the methods were again applied only to the variants that
are considered genotyped. The power of each method was estimated as the proportion
of p-values less than 0.05.
In addition to the single interaction model, we also considered models in which we
have two interacting SNPs. In particular, simulated outcomes are based on the model







where c1 and c3 are the indices of two randomly selected variants from ASAH1 and c2
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and c4 are the indices of two randomly selected variants from SPARC. Variants were
selected without regard to whether they are genotyped or not. Under this model, we
again considered sample sizes of n = 500, 1000, and 1500, but here, we simulated 5,000
data sets to each of which we again applied the SKIT based and competing methods.
Power was again computed at the 0.05 level.
4.2.4 Genetic Association Study of Infant Birth Weight
Birth weight is known to be an important predictor for subsequent adverse health
outcomes (33, 63). Consequently, it is of substantial interest to understand the factors
influencing birth weight including genetic components. Recent studies have found evi-
dence that genetic factors do play a role in birth weight (43, 127), but there has been
limited study of epistatic interactions.
To illustrate our methods, we applied our SKIT and the competing methods to
genotyping data from 863 singleton, live births from women of European ancestry in
the Pregnancy, Infection and Nutrition (PIN) Cohort (129). Briefly, we restricted
attention to four pathways which are plausibly related to birth weight and related
birth outcomes. Following quality control to remove monomorphic SNPs and SNPs
with low allele frequency, 1036 SNPs across 72 genes were available for analysis. We
grouped the SNPs into SNP-sets formed based on the 72 genes. We then tested for
the interaction between each pair of SNP sets on quantitative birthweight values using
the linear SKIT as well as SKIT under the 2-way interaction, quadratic, and squared
IBS kernels. We also applied the competing minP, tail strength, product p-value, and
PCA based approaches previously used in the simulations. All of the methods adjusted





Type I Error Results
Simulation results examining the type I error under each of Scenarios A–D are
presented in Table 4.1. The GATES method is somewhat anti-conservative under all
of the scenarios which may be due to differential capacity in capturing the effective
number of tests depending on the genetic architecture (55).
Under Scenario A, we see that the SKIT based methods all protect the type I error
rate at the 0.05 level. The linear SKIT is conservative under this scenario, which reflects
results from other groups finding that linear testing under the KMR is sometimes
conservative (81, 74). Under this global null in which the outcome does not depend
on the main effects or the interaction effects, all of the competing methods except for
GATES also appear to correctly control the type I error rate.
Under Scenario B in which main effects of both SNP-sets influence the outcome, the
type I error of all of the SKIT based methods are correctly controlled. In addition to the
GATES method, the PCA method is also slightly anti-conservative, as expected, since
the mean model is not correctly captured. The results are similar under Scenario C
in which the main effect of ASAH1 influences the outcome, but neither the interaction
nor the main effect of SPARC affect the trait value, though the linear SKIT is again
somewhat conservative.
When the model is somewhat more sophisticated, as in Scenario D, then none of the
competing methods correctly control type I error. The linear SKIT also fails to control
the type I error as it operates under the assumption that there are no interactions
within the SNP-sets. However, the SKIT under the 2-way, quadratic, and squared IBS
kernels still correctly protect the type I error, even in the presence of complex effects.
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Power Results
Power simulation results under the two-SNP interaction models are given in Table
4.2.
Among the SKIT based methods, the linear SKIT tended to have higher power
across all three scenarios, despite being conservative under the null, which is expected
since the data are simulated under a simple linear model. Generally, the two-way
interaction and quadratic kernels also have higher power than the squared IBS kernel,
though under more complex scenarios, the squared IBS kernel may perform better.
Among the non-SKIT based methods, the tail strength and product p-value methods
tend to have competitive power across scenarios. Although the PCA based approach
has considerably higher power under the scenario in which neither interacting variant is
typed, it loses power under the scenarios in which one or both of the interacting SNPs
is typed.
In comparing the SKIT based approaches to the non-SKIT based approaches, we
see that the SKIT based methods tend to have much higher power in the scenarios (E
and F) in which at least one of the interacting loci is not genotyped. This is possibly
due to the fact that SKIT captured LD between SNPs and better allows the genotyped
SNPs to capture the effect of the causal variant. In contrast, the minP, tail strength,
and pvalue product methods all rely on testing individual pairs of variants. The PCA
based approach can also harness correlation, but suffers from lower power relative to the
better SKIT kernels since these PCs do not utilize outcome information. When both
of the causal variants are genotyped under Scenario G, then the competing methods
tended to have higher power as one may anticipate. Overall, power was substantially
lower for all methods in the scenario in which both interacting SNPs were typed. This
is due to the relatively low minor allele frequencies of the interacting variants. However,
the relative powers are still useful for comparing the performance of different methods.
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The power comparisons under the model in which we allow multiple interactions are
presented in Table 4.3. As expected, the linear SKIT based method tends to have higher
power than the competing tests. The PCA based approach also compares favorably
to the SKIT based methods but the linear SKIT still offers considerably higher power
when the sample size is smaller. Interestingly, the as the sample size increases, the
advantage of the SKIT methods tends to diminish – though the linear SKIT still tends
to be much better than the competitors. This may be due to the fact that in addition to
having an interaction term, the homoscedasticity violations arrising from the additional
interaction terms may actually lend greater power to the competing approaches.
Although the competing methods can sometimes have higher power than the pro-
posed SKIT methods under some scenarios, we emphasize that all of the models con-
sidered for assessing power do not include main effects since several of the competing
methods fail to protect type I error rate. Thus, given the difficulties in guaranteeing the
false positive rate, SKIT is still an attractive alternative or supplementary approach to
competing methods.
4.3.2 Birthweight Analysis Results
The top results for the birth weight analysis are presented in Table 4.4. Specifically,
considering each of the 72× 71/2 = 2556 pairs of SNP-sets and testing for interactions
across the SNP-sets, we identified the smallest p-value for each pair (across the different
methods) and focus attention on the top 10 pairs of SNP sets.
From Table 4.4, it is evident that the linear SKIT, despite performing well in sim-
ulations, tends to be less significant than the other SKIT methods and several of the
competing methods. This better reflects the findings from the type I error simulations
indicating that the linear SKIT can be highly conservative, particularly when sample
size is modest. In general the SKIT based approaches tended to compare well against
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the other methods: althought the SKIT does not always yield the strongest statistical
significance across all of the pairs of SNP-sets, it is often the most significant method
and it should again be noted that many competing methods may not adequately control
the type I error rate.
At the bonferroni corrected level α = 0.05/2556 = 2.0× 10−5, only a single pair of
SNP-sets is called significant by any of the methods: testing for interactions between
SERPINE1 and FGFR4 on birth weight. The SKIT under a squared IBS kernel yields
a significant p-value of 2.9×10−6. If we use an alternative criterion for significance and
control the FDR at the 0.10 level, then SKIT under the IBS kernel would also identify
significant interactions between the TNFRSF1B and IL12A genes (p = 2.8 × 10−5,
FDR = 0.030) and between the LEP and IL2 genes (p = 2.8 × 10−5, FDR = 0.030).
Since these genes lie within candidate pathways related to birth outcomes such findings
would make sense, though further validation is required.
4.4 Discussion
Kernel methods are popular within the realm of high-dimensional data techniques
because they not only address many of the difficulties concerning dimensionality, but
also allow for powerful and flexible approaches to detect complex and possibly non-
linear correlations within feature sets. The additive kernel machine methodology used
here extends the natural flexibility of the kernel functions. By applying a KPCA in
conjunction with this methodology, we are able to tease out an interaction space. Hav-
ing access to this interaction space allows for implementation of a hypothesis test to
determine significance for epistatic interactions. Previous methods testing for epistatic
interactions can often have an inflated type I error and may only work well for certain
scenarios when both causal variants are typed. Our proposed SKIT procedure protects
type I error while capturing the LD between SNPs in a set to better detect the effects of
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the potentially untyped causal variants. The additive kernel machine does not require
a direct interaction specification and can accommodate complex interactions that can
be on a large scale such as a gene-gene level interaction. In using this framework, we
can isolate these gene pairs for follow-up analysis without having to address a large
multiple testing correction which typically occurs when running an individual SNP-
SNP interaction analysis. The identification of epistatic interactions is key in better
understanding the genetic impact many variants have on complex diseases. Simula-
tion results for the SKIT show reasonable type I error around .05 for most scenarios.
There was some deviations from .05 when using the linear SKIT due to the underlying
linear assumptions which were not always true. These deviations, however, were not
seen when using the SKIT without a linear assumption. In cases where both causal
variants were typed, competing methods tended to outperform the SKIT in power sim-
ulations. It is often the case, though, that the true causal SNPs are not typed, and in
all scenarios involving this the SKIT outperformed its interaction testing counterparts.
The methodology described in this paper is only given in the context of testing for
interactions between two marker sets. This can easily be extended, though, to examine
interactions between multiple marker sets with the simple addition of more h?(·) func-
tions which would be based on these additional marker sets. However, this does carry
the extra computational burden of calculating an empirical basis for each new marker
set. The additive kernel machine model along with a KPCA presented here provides
both a powerful and flexible framework for the discovery of novel epistatic interactions
which can be applied to high-dimensional data.
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Figure 4.1: LD Plot of the ASAH1 gene used in simulations.
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Figure 4.2: LD Plot of the SPARC gene used in simulations.
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Table 4.1: Type I Error for simulations with SPARC and ASAH1 genes
Scenario n Linear 2-way Quad. Sq. IBS minP GATES TS Prod. PCA
A 500 0.020 0.050 0.049 0.049 0.050 0.083 0.047 0.048 0.054
1000 0.021 0.052 0.052 0.052 0.051 0.083 0.047 0.048 0.053
1500 0.020 0.050 0.052 0.051 0.050 0.079 0.045 0.046 0.053
B 500 0.054 0.049 0.049 0.049 0.049 0.084 0.046 0.046 0.063
1000 0.052 0.052 0.051 0.052 0.050 0.082 0.047 0.048 0.062
1500 0.052 0.051 0.051 0.049 0.049 0.078 0.044 0.045 0.058
C 500 0.031 0.052 0.051 0.050 0.048 0.083 0.046 0.047 0.068
1000 0.029 0.050 0.051 0.051 0.051 0.084 0.049 0.049 0.065
1500 0.030 0.051 0.052 0.052 0.051 0.080 0.045 0.046 0.062
D 500 0.065 0.050 0.051 0.051 0.262 0.309 0.095 0.099 0.101
1000 0.065 0.051 0.051 0.052 0.294 0.336 0.099 0.104 0.093
1500 0.065 0.054 0.054 0.052 0.301 0.340 0.098 0.104 0.087
Linear, 2-way, Quad, and Sq. IBS denoted the Linear SKIT and SKIT under the 2-way
interaction, quadratic, and squared IBS kernels, respectively.
TS and Prod denote the tail strength and p-value product methods.
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Table 4.2: Power Simulations: Single interaction models
Scenario n Linear 2-way Quad. Sq. IBS minP TS Prod. PCA
E 500 0.518 0.231 0.240 0.179 0.154 0.150 0.154 0.208
1000 0.822 0.468 0.456 0.382 0.320 0.340 0.342 0.406
1500 0.900 0.640 0.607 0.586 0.480 0.520 0.520 0.554
F 500 0.638 0.316 0.312 0.258 0.176 0.196 0.194 0.206
1000 0.914 0.600 0.585 0.500 0.440 0.442 0.448 0.438
1500 0.980 0.775 0.763 0.699 0.614 0.628 0.640 0.600
G 500 0.034 0.066 0.057 0.070 0.090 0.090 0.096 0.072
1000 0.048 0.074 0.066 0.057 0.096 0.110 0.114 0.064
1500 0.078 0.075 0.075 0.089 0.132 0.154 0.154 0.040
Linear, 2-way, Quad, and Sq. IBS denoted the Linear SKIT and SKIT under the
2-way interaction, quadratic, and squared IBS kernels, respectively.
TS and Prod denote the tail strength and p-value product methods.
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Table 4.3: Power Simulations: Two-interactions model
n Linear 2-way Quad. Sq. IBS minP TS Prod. PCA
500 0.277 0.206 0.206 0.185 0.169 0.188 0.191 0.200
1000 0.404 0.333 0.338 0.309 0.300 0.317 0.330 0.331
1500 0.459 0.411 0.401 0.393 0.397 0.412 0.421 0.438
Linear, 2-way, Quad, and Sq. IBS denoted the Linear SKIT and SKIT under the
2-way interaction, quadratic, and squared IBS kernels, respectively.
TS and Prod denote the tail strength and p-value product methods.
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Table 4.4: Top results for PIN study epistatic interactions on birth weight
Gene 1 Gene 2 Linear 2-way Quad. Sq. IBS minP TS Prod. PCA
SERPINE1 FGFR4 0.03 0.00007 0.00004 0.000003 0.0003 0.0011 0.0001 0.02
TNFRSF1B IL12A 0.56 0.41 0.46 0.00003 0.65 0.66 0.43 0.39
BLK BAX 0.09 0.001 0.003 0.01 0.01 0.0001 0.0002 0.01
LEP IL2 0.09 0.0004 0.0004 0.0001 0.01 0.01 0.004 0.02
IL2 FGFR4 0.33 0.0006 0.0007 0.004 0.02 0.0002 0.0003 0.0052
PGF EDN1 0.07 0.11 0.16 0.32 0.13 0.14 0.14 0.0005
KLDR1 AHR 0.07 0.004 0.01 0.01 0.07 0.0005 0.002 0.002
THBS4 KIR3DL3 0.06 0.001 0.001 0.003 0.001 0.002 0.002 0.02
LEP IL12A 0.7 0.08 0.08 0.09 0.001 0.009 0.002 0.06
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Chapter 5
Testing Rare Variants with Common Variant Interaction
5.1 Introduction
While genome wide association studies (GWAS) were able to identify a large number
of individual common genetic variants associated with a range of diseases and traits
(57), the identified common variants tend to have modest effect sizes and consequently
explain only a fraction of the trait variability that is believed to be due to genetic factors
(99, 102). Increasingly, rare variants are believed to have strong effects on phenotypes
since they have not been subjected to the same evolutionary pressures and consequently
may explain much of the missing heritability (40). Recent advances in DNA sequencing
technology (104, 2) have now enabled the detection of rare genetic variants in a large
number of individuals, spurring the development of population based sequencing studies
to identify rare genetic variants associated with complex traits. However, statistical
methods for analysis of rare variants have lagged behind technological advances and
scientific interest.
Standard methods for the analysis of GWAS, which involves analyzing the marginal
association between each common variant and the trait, tends to be under-powered for
analysis of rare variants due to the low allele frequencies: many variants are observed
in only a single individual in the entire study. Therefore, region based analysis has
become the standard mode of analysis for rare variants (4, 52, 76, 77, 79, 97, 110,
111, 123, 168, 18, 165). This involves grouping the rare variants within a region (such
as a gene) and testing the cumulative effect of the entire group of rare variants on
the trait value. While initial methods focused on averaging the variant values within
a region, more sophisticated methods have been developed. One particular method
that has been successfully applied and that is commonly used within many analysis
pipelines is the sequence kernel association test (SKAT) (165). SKAT operates using
the semiparametric kernel machine modeling framework first proposed for analysis of
gene expression data (88, 90) and later extended to analysis of GWAS (71, 161, 82).
Briefly, SKAT allows for flexible, possibly nonparametric modeling of the effect of the
rare variants on the outcome. The effect of the rare variants on the outcome is assessed
by exploiting the connection between kernel machine regression and linear mixed models
and using a variance component score test (88, 90, 121). A wide range of methods are
built upon the SKAT (74, 24, 118, 75, 85).
Within the context of rare variant analysis, focus has been primarily on the rare
variant effects. In practice, however, many initial sequencing studies include sequencing
of candidate genes which are known to contain common variants related to the traits
(113). The presence of common variants associated with the outcome poses a challenge
for many rare variant tests including the SKAT. In particular, the dimensionality of the
common variants can be modestly large making it difficult to adjust for the common
variant effects, particularly since it is generally unknown which of the common variants
are truly associated with the outcome. At the same time, the common variants may
have complex effects on the outcome, such as through epistasis (variant-variant inter-
action) among themselves. Finally, there is even the potential for interactions between
the common variants and the rare variants. Recent work on joint analysis of common
and rare variants focuses on testing for their joint effect which is rarely of primary
interest (61). New methods are required.
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Focusing on continuous outcomes, in this paper, we propose a practical strategy for
accommodating common variants within the context of rare variant analysis. In par-
ticular, we proposed to use an additive kernel machine model (26) to additively model
the effects of the common variants and the rare variants through separate functions.
We exploit the connections between linear mixed models and additive kernel machines
to test for the effect of the rare variants while adjusting for the possibly complex ef-
fects of the multi-dimensional common variants. As in SKAT, a variance component
test is again used to test for the significance of the rare variants. In addition, the
use of kernel machines is a natural approach for flexible, potentially nonparametric,
multi-dimensional modeling of the common variant effects, allowing for complex, even
interactive, effects. At the same time, we are sharing the advantages of SKAT in terms
of flexible modeling of the rare variant effects and in rapid p-value computation through
the connections with mixed models.
We further consider the possibility of interactions between the common and rare
variants. The difficulty in directly applying the additive kernel machine framework
is that the outcome depends on separate functions of the common and rare variants,
implicity indicating an inability to model interactions across common and rare vari-
ants – though interactions among common variants and among rare variants along are
captured. To address this challenge, we develop a strategy for isolating the main com-
mon variant effects from the rare variant and rare variant by common effect interaction
effects through the use of kernel principal component analysis. Specifically, we ap-
proximate a basis for the full functional space spanned by both the common and rare
variants and then take the residual space after projecting out the main effects of the
common variants. The residual space includes the effects of the rare variants and the
interactions between the common and rare variants based upon which we can test for
the rare variant effects even in the presence of interactions.
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This project advances the field in several ways. First, we address an important
practical problem within the context of rare variant analysis via application of the
additive kernel machine model. Second, develop a strategy for decomposition of the
total variant effects into the contributions from the main common variant effects and
from the rare and rare by common interaction effects. Finally, we systematically assess
our approach through simulations and through application to a real sequencing data
set looking at the association between rare variants within a candidate region and
quantitative cholesterol levels.
The remainder of this paper is organized as follows. In the next section, we review
and describe the basic additive kernel machine testing framework. In Section 3 we con-
sider the problem of testing for rare variant effects when there may be interactions with
the common variants and we describe the proposed solutions. We present simulations
verifying the type I error rate and power of our proposed methods in Section 4 and we
apply our methodology to real a cholesterol data set in Section 5. We conclude with a
brief discussion.
5.2 ALSKM of Both Common and Rare Variants
In this section we describe the proposed additive kernel machine modeling frame-
work for testing the rare variants within a region while in the presence of common
variants. We first describe the fundamentals of kernel machines followed by the addi-
tive modeling framework considered here before presenting the approach for association
testing. We assume, here, that there are no interactions between the common and rare
variants.
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5.2.1 Kernel Machine Methods
Initially popularized by support vector machines (30), kernel machine methods form
the basis for many multi-dimensional modeling techniques due to their flexibility and
success in capturing complex effects (117, 37, 14, 7). The essence of the framework lies
in the definition of a kernel function, K(·, ·). A kernel function is a similarity based
metric which measures pairwise-similarity (distance) between individuals in the data.
Through K(·, ·) we can generate a reproducing kernel Hilbert space H. Under the
regularity conditions given in Mercer’s Theorem, H is also uniquely implied by K(·, ·)
and is spanned by orthogonal basis functions φ(·) = {φ1(·), · · · , φJ(·)} where J could
potentially be infinite. Using this spanning set of basis functions we can generate any
function h(·) ∈ H such that h(z) = ∑Jj=1 ωjφj(z) in what is known as the primal
representation with ω = {ωj}Jj=1 as a vector of constants (31). Practically, however,
this can prove difficult when J is high-dimensional since explicit specification of φ(·) is
challenging.
The Representer Theorem (69) uses the kernel trick which is based on inner prod-
ucts to map from a possibly infinite dimensional space, such as what is seen in the
primal representation, to a finite space. By using this theorem we avoid having to
explicitly map a complex feature space. This greatly simplifies the specification of h(·)




l , z) = Kα where
α = {α1, ..., αL} are constants, L is an integer, {z∗1, ..., z∗L} ∈ Rp, and K is the pos-
itive semidefinite kernel matrix with the (i, j)th element equal to the kernel function
evaluated at K(zi, zj). Under the dual representation we need only specify the kernel
function and estimate the finite vector α (31). Methods based off of kernel functions
have become popular within the realm of genomics due to the computational ease
the kernel trick provides in avoiding the need to map out a potentially complex and
high-dimensional function space.
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5.2.2 Additive Kernel Model
We will use an additive kernel machine model to separately model the effects of
the common and rare variants within a region. Specifically, we define yi to be the





vectors of p1 common variants p2 rare variants, respectively, within a region for the
ith individual. Then letting xi denote the additional demographic and environmental
covariates (such as age, gender, ethnicity, etc.), we related the outcome to the variants
and the covariates through the model





′) + εi = xiβ + h(zi) + εi (5.1)
where β is the vector of regression coefficients for the covariates (augmented by a
column of 1’s to allow for an intercept), and h(·) is an unknown centered smooth
function. Under the kernel machine framework, we allow h(·) to lie in a function space
HK which is generated by a positive definite kernel function K(·, ·) with corresponding
kernel matrix K which is the n×n matrix with (i, i′)th element equal to K(zi, z′i). With
a sufficiently rich kernel, the function space h(·) ∈ HK contains the full function space
for features in z(C), z(R), and interactions that may exist between the two sets.
The kernel model given in (5.1) can be further generalized by splitting the function
space to get the kernel machine model
yi = xiβ + hC(z
(C)
i ) + hR(z
(R)
i ) + εi (5.2)
where hC(·) ∈ HC is a function of just the common variants z(C) and hR(·) ∈ HR
is a function of just the rare variants z(R). Each of HR and HC are generated by
kernel function KC(·, ·) and KR(·, ·) with corresponding kernel matrices KR and KC ,
respectively
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Under the kernel machine framework, estimation of β, hC(·) and hR(·) proceeds via











j ) + αRjKR(zi, zj)]}2 − λCαTCKCαC − λRαTRKRαR(5.3)
with λC and λR as tuning parameters controlling the tradeoff between goodness of fit
and complexity. Using the dual representation of h(z) = Kα we find estimates for
parameters β, hC(·) and hR(·) in model (5.2) to be
βˆ = [xT (I + λ−1C KC + λ
−1
R KR)






C KC(I + λ
−1






R KR(I + λ
−1




Estimation of λC and λR can be done via GCV. Alternatively, we can also draw upon
connections between additive kernel machine models and linear mixed models (LMM)
to take model (5.2) to correspond to a mixed model with fixed effects β, and vectors of
subject specific random effects hC and hR each with mean 0 and variance τCKC and
τRKR such that the model becomes




(with ? equaling C or R), where λ? is the tuning parameter seen in (5.3).
The best linear unbiased predictor βˆ = (XTV−1X)−1XTV−1y is equivalent to the MLE
found for β in the original likelihood when V = σ2I + τCKC + τRKR. Using the LMM
framework allows us approach estimation for this model using a restricted maximum
likelihood (REML), This includes estimating unknown parameters (τC , τR, ρC , ρR, σ
2)
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as a part of the REML covariance structure instead of using GCV.
More important than in estimation, the connection with LMMs allows for powerful
testing of the rare variant effect while simultaneously modeling the common variant
effects through a variance component score test.
5.2.3 Testing Rare Variant Effects Under Additive Kernel Model
Testing for the association between the rare variants and the outcome corresponds
to testing H0 : hR(z
(R)) = 0 since the the outcome depends on the variants in zR only
through the function hR(·) such that under the null, the model in (5.2) can be rewritten
as
yi = α0 + x
T
i β + hC(z
(C)
i ) + εi. (5.5)
Recalling that h(Z(R)) is can be treated as a vector of subject specific random effects
with mean 0 and variance τRKR, due to the connections between LMMs and the kernel
machine framework, then an equivalent null hypothesis is H0 : τR = 0. Testing this
hypothesis can proceed via a variance component score test under the LMM defined in
(5.4). Specifically, similar to previous work, we can construct the score statistic
QKR =
(y − xβ̂ − ĥC(z(C)))′KR(y − xβ̂ − ĥC(z(C)))
σ̂2
(5.6)
Estimates for β̂, ĥC , and σ̂ can be found using a REML optimization under the null
model given in (5.5) or through using GCV. Since the null value for τR lies on the
boundary of the parameter space, under H0, QKR follows a mixture of chi-squares









0 and P0 is the projection matrix under the null model given in (5.5). This
allows for rapid, analytical p-value computation.
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5.3 Accommodating Epistasis Between Common and Rare Variants
A key challenge in analysis of rare variants and common variants lies in the potential
for epistatic effects between the common and rare variants. Variant-variant interaction
is believed to be highly prevalent across the genome. Accommodation of these interac-
tions in rare variant analysis necessary. To do this, we will again employ the additive
kernel machine framework, but due to difficulties associated with directly specifying a
kernel function that captures the main rare variant effects along with the rare variant
by common variant interactions (without also capturing main common variant effects),
we will instead develop an indirect strategy for inferring the kernel function for the
main rare variant effects and their interactions with the common variants.
5.3.1 Additive Kernel Machine Model with Interactions
Similar to earlier, we will use an additive kernel machine model to relate the rare
variants and the common variants to the outcome, except now we also allow for inter-
actions between the rare and common variants. Specifically, we have the same model
(5.1) as before, but instead of using (5.2) now we choose operate under an alternative
decomposition:
yi = xiβ + hC(z
(C)
i ) + hRix(zi) + εi (5.7)
where β and hC(·) are as before, but now hRix(zi) is now a function of both the common
and rare variants and represents the main rare variant effects as well as the effects of
the interactions between the rare variants and the common variants, but not the main
effects of the common variants. Since we are still using the kernel machine framework,
hRix lies within a reproducing kernel hilbert space HRix generated by a positive definite
kernel function KRix(·, ·) with corresponding kernel matrix KRix.
Also, as earlier, we can draw a relationship between kernel machine models and
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LMMs to have (5.7) correspond to a mixed model
y = Xβ + hC + hRix + ε (5.8)
where parameters are as before but now hRix is a vector of subject specific random
effects with mean zero and variance τRixKRix.
Testing for the total rare variant effect then becomes testing whether H0 : hRix(·) =
0 which, due to the connection with LMMs, can again be tested by using the equivalent
null H0 : τ = 0. In principle, this can be done by using the same variance component
score test as used earlier except we replace KR with KRix. Unfortunately, this is not
quite so simple. The problem is that it is difficult to specify a kernel capturing the main
effects of the rare variants as well as the rare variant by common variant interactions
without also capturing the common variant effects.
5.3.2 Approximating the Basis for Rare Variant and Interactions
Specification of the kernel function that captures interactive effects between the
common, z(C), and rare variants, z(R), jointly with the main effects for z(R) without
contamination from the main effects in z(C) is generally difficult. For example, set-
ting KRix(·, ·) to be a quadratic kernel would include the main effects of z(R) and their
interactions with z(C), but also included would be the main effects of z(C). There-
fore, we provide an alternative approach based on decomposing the full space H in its
constituents.
We can easily specify kernels for HC , the space containing the main effects of the
common variants in which hC(z
(C)) lies, andHK , the full function space for both feature
sets and their interactions in which h(z) from (5.1) lies. It is easily seen that the full
function space consists of three disparate parts, the space for common variants, HC ,
containing features in z(C), the space for rare variants, HR, for features in z(R), and
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Hix containing their interactions. Therefore, by construction we know that HK =
HC + HR + Hix. Using this same logic we see that the joint space for HR and Hix
is just the difference between the full space and the function space for HC such that
HR + Hix = HK − HC . When specifying a kernel for each function space we are
implicitly defining the feature space in which it lies. A kernel can be broken down
using a kernel principal components analysis (KPCA) as first described by Scho¨lkopf et
al. (1997) (138). Using the pieces from the KPCA we can construct an empirical bases
for HK written as Φ̂ = [φ̂1, . . . , φ̂n]. Doing this also for HC gives us the components
we need to then specify an empirical basis for HRix = HR +Hix.
By applying a KPCA to kernel K we can obtain eigenvectors U = [u1, . . . ,un] as
well as eigenvalues Λ = diag(λ1, . . . , λn) where λ1, . . . , λn. Using these pieces, we then
generate an approximate basis for HK denoted as Φ̂ = [φ̂1(z), . . . , φ̂n(z)] = UΛ1/2.
Similarly, a KPCA can be applied to KC to generate ξ̂ = [ξ̂1(z




1 . An approximate basis for HRix, denoted Ψ̂ = [ψ̂1(z), . . . , ψ̂n(z)], can now be
generated using Φ̂ and ξ̂. Using the orthogonal projection of Φ̂ onto the space spanned
by ξ̂ we find
Ψ̂ = Φ̂− ξ̂(ξ̂′ξ̂)−1ξ̂′Φ̂ (5.9)
The empirical basis, Ψ̂, for HRix can be used to generate an empirical kernel by
taking KRix = Ψ̂Ψ̂
′.
Once we have obtained KRix the additive kernel machine testing approach developed




We conducted a series of simulations to verify the type I error rate of our proposed
additive kernel machine test and to examine the power under a range of scenarios.
For both the type I error and empirical power assessment, we used a coalescent
model (131) to simulate DNA sequencing information on a 3 kilobase region with LD
patterns mimicking a European population. We simulated 20,000 individual haplotypes
which were then paired to generate genotype information on diploid individuals. Within
this 3 kb region, there are a total of 50 variants of which 26 are considered rare (with





i denote the genotypes of the common variants and rare variants,
respectively, for the ith individual in each data set. We then generated two covariates
as xi1 ∼ N(29.2, 21.1) and xi2 ∼ ber(0.506). Outcomes for each individual, yi, were
simulated using the variants and covariates.
5.4.1 Type I Error
To assess the size of our test, we considered several different models.
Under the first null model (Null Model A), we simulated outcomes under the global
null in which neither the common nor the rare variants influence the outcome. Specifi-
cally, the outcome variable for the ith individual in each simulated data set was gener-
ated as
yi = 0.03xi1 + 0.5xi2 + εi
where εi ∼ N(0, 1).
Under the second null model (Null Model B), we allowed the simulated outcomes
to depend on the main effects of the common variants, but neither the main effects of
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the rare variants nor their interactions with the common variants, using the model







where c1 and c2 are the indices of the two causal, common, variants. c1 and c2 are ran-
domly selected from among the common variants. All other variables are as before. A
third model was designed under the null containing an interaction between the common
variants,













We considered sample sizes of n = 500, 1000, 1500, and 2000 individuals. For each null
model and sample size, we simulated 2000 data sets.
We applied the our proposed strategy testing for rare variants and any possible
interactions while simultaneously adjusting for common variants. In particular, we
considered the additive kernel machine model using the linear, 2-way interaction, and
squared IBS kernels with adjustment for the main rare variant and rare variant by
common variant interactions. We note that due to the low allele frequencies, not all
of the rare variants are observed in any given data set such that we only applied our
methods to the observed rare variants. For a given model and sample size, we estimated
the size of the test as the proportion of p-values less than α = 0.05.
The type I error simulation results are given in Table 5.1. The results indicate that
the proposed method using the additive kernel machine model correctly control the
type I error across both null models and sample sizes.
5.4.2 Power
To examine the empirical power of our proposed methods, we conducted simulations
using similar models as in the type I error simulations except here the rare variants are
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allowed to influence the outcomes. We considered three different alternative models.
Under the first alternative model, the outcome depends on the common variants
and the main effects of the rare variants, but not the interactions between the common
variants and the rare variants. Specifically, we simulated outcomes based on the model:










where c1 and c2 are the indices of two randomly selected common variants and z
(R)
i
are the genotypes of the rare variants (both observed and unobserved) and β(R) are
the coefficients of the rare variants. We randomly selected 20 rare variants to be
“causal” and for each causal variant, the corresponding regression coefficient was set
to 0.15| log10 q| where q is the MAF of the particular variant. The coefficients for the
remaining non-causal variants was set to zero.
Under the second alternative model, the outcome depends on the interaction be-
tween the common and rare variants but not the main effects of the rare variants using
the model














efficient for the interaction terms was set to 0.15| log10(.5689q(R))| where q(R) are the
MAFs of the rare variants.
Under the final alternative model, the outcome depends on both the main effects
of the rare variants and also the interactions between the common variants and rare
variants. We simulated outcomes based on the model:













all parameters were the same as in the previous model with β(R) set to earlier effect
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sizes for the causal variants as in the first alternative model.
For each model, we considered sample sizes of n = 500, 1000, 1500, 2000 and for
each sample size and model, we simulated 1000 data sets. We applied each method to
each of the data sets, again noting that not all of the rare variants are observed in any
given data set such that we only applied our methods to the observed rare variants —
the causal variants are frequently unobserved. Then the power was estimated as the
proportion of p-values less than α = 0.05.
The power simulation results are presented in Table 5.2. Under the first model,
the 2-way IX and squared IBS kernels tend to have higher power. These results are
anticipated as these models better capture the true underlying model. Interestingly,
when the outcome depends on just interactions or both the main effects of the rare
variants as well as their interactions with the common variants, the power is fairly
uniform across the kernels. This is somewhat unexpected, but this may be due to the
fact the increased degrees of freedom of the test associated with capturing interaction
effects and main effects of the rare variants. It may also be due to the fact that relatively
few of the interactive variants are observed.
5.5 Analysis of Resequencing Data for Cholesterol Traits
Cholesterol levels are associated with adverse outcomes such as heart disease, stroke,
diabetes, and high blood pressure. Recent studies have identified several loci which seem
to influence levels of high-density lipoprotein (HDL), good cholesterol, and low-density
lipoprotein (LDL), bad cholesterol. It is clinically important to better understand
the genetic mechanisms underlying cholesterol levels as this may further inform future
therapy and clinical care (66, 73).
Testing procedures were run on a dataset containing 1898 subjects with 85 genetic
loci and 8 relevant linear adjusting covariates. The genetic dataset was divided into
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two sets based on minor allele frequency (MAF), a common set (MAF> .03) which con-
tained 12 variants, and a rare set which had 73 variants. We used 3 different outcomes,
first examining an overall cholesterol level and then separately looking at HDL and
LDL levels. We applied our method first testing the main effects and interactions for
the rare variants while adjusting for common variants. We then applied our secondary
method which only tests for the main effects while adjusting for common variants. In
addition, we applied a similar kernel method test by Liu et al. (90) which can only test
for main effects without adjusting for other complex variants. In order to do this we
ran this KM testing procedure three times, first testing both common and rare variants
together, then testing each set separately. While none of the results were significant
when looking at overall cholesterol levels and LDL, we did find a marginal association
with HDL and rare variants along with interactions between these variants and the
common ones using the interaction kernel. The results from this are given in table 5.3.
5.6 Discussion
The effects of rare variants and the role they play through epistatic interactions
provides a clear focus for investigators in search of complex, de novo effects involving
multiple loci. Previous methods such as the SKAT have been successful in many new
discoveries of such variants. However, these methods cannot make complex covariate
adjustment which can lead to an inflated type I error. This has been a common chal-
lenge within the realm of rare variant testing. The methods presented in this paper
not only offer a solution in adjusting for these common variants, but by jointly im-
plementing a KPCA, we can also include epistatic interactions between common and
rare variants in our procedure. The additive kernel machine model contains properties
which can ease computational burden and α level restrictions. Since it is also a SNP-
set based procedure, sets can be formed at a biologically interpretable unit, such as a
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gene or pathway, easing interpretation of hypothesis testing results. Procedures such
as those presented here can help investigators further explore how genes and pathways
affect certain traits and diseases. It is through such discoveries that researchers will
gain insight and a better understanding of the biological forces behind many medical
malignancies.
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Table 5.1: Type I Error: Rare+Rare× Common adjusting for Common
Model N 2-Way Sqrd IBS













Table 5.2: Power: Rare+Rare× Common adjusting for Common
Model N 2-Way Sqrd IBS













Table 5.3: Cholesterol Study Results
2-Way Sqrd IBS
Cholesterol Main Effects and IX for Rare Variants a 0.643 0.323
Main Effects for Rare Variants b 0.471 0.585
KM Test-All c 0.157 0.530
KM Test-Common d 0.139 0.301
KM Test-Rare e 0.621 1.000
CLHDL Main Effects and IX for Rare Variants 0.007 0.680
Main Effects for Rare Variants 0.153 0.222
KM Test-All 0.416 1.000
KM Test-Common 0.402 0.721
KM Test-Rare 0.395 0.923
LDL Main Effects and IX for Rare Variants 1.000 0.637
Main Effects for Rare Variants 0.481 0.667
KM Test-All 0.276 0.747
KM Test-Common 0.290 0.475
KM Test-Rare 0.730 1.000
aTesting rare variants and interactions with common variants while adjusting for common effects
bTesting main effects for rare variants while adjusting for common effects
cLiu kernel method testing procedure testing all variants (common and rare) together
dLiu method with only common variants
eLiu method with only rare variants
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APPENDIX I
Regularity conditions for 3.3.1
Regularity Conditions
The following regularity conditions are necessary to establish the consistency of Θˆ.
• Condition 1: For the parameter Θ = (θ1, . . . , θk) and observations D = (X,Z(1), Z(2), Y )
which have the pdf f(D,Θ) with respect to measure µ, f(D,Θ) has a common























• Condition 2: The Fisher information matrix, I(Θ), is finite and positive definite











• Condition 3: For Θ there exists an open subset ω containing Θ0, the true param-
eter, such that for most D the density f(D,Θ) has all third derivatives
∂3logf(D,Θ)
∂θiθjθl
for all Θ ∈ ω
and there exists functions Mijl where∣∣∣∂3logf(D,Θ)∂θiθjθl ∣∣∣ ≤Mijl(D) for all Θ ∈ ω
mijl = EΘ0 [Mijl(D)] <∞
• Condition 4: Since Ω is a rectangle of cross products of intervals we know that
the parameter space near Θ0 behaves like a closed set.
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Letting l(.) denote the REML given in 3.8 and the true value of Θ be Θ0 we can




u : sup||u||=C l(Θ0 + αnu) < l(Θ0)
] ≥ 1− 
Where αn = n
− 1












Where VΘ is the derivative of V with respect to the k
th component of Θ. So, with
probability 1 −  there exists a local maximum in the ball (Θ0 + αnu : ||u|| ≤ C).
This implies that there is a local maximizer, Θˆ such that ||Θˆ − Θ0|| = O(αn). Under
regularity condition 4 we know that the intersection of the parameter space Ω and the
closure of a neighborhood around Θ0 constitute closed intervals so there also exists a
local maximizer on this set even when Θ0 is on the boundary of Ω. Let L
′(Θ0) be the
gradient vector of the loglikelihood function L. Using a standard Taylor exponsion on
the likelihood function and the condition that an = o(1) we see














( |XTV−1(Θ0 + αnu)X|
|XTV−1Θ0X|
)
Since n−1/2L′(Θ0) = O(1) ⇒ αnL′(Θ0)Tu is on the order of O(n1/2αn) = O(nα2n).




n(1 + o(1)) dominates








dominated by the same term, so by choosing C large enough this theorem holds when




Letting Ω = Ω1 × Ω2 × Ω3 × Ω4 × Ω5, without loss of generality we can as-
sume Θ1 is a left endpoint of Ω1 and the other components of Θ are on the in-















. Using N as a multivari-
ate Gaussian random variable with mean Θ and covariance I−1(Θ0) while restricting
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